Document:

EX-10.1

 Exhibit 10.1 

SUBSCRIPTION AGREEMENT 

This SUBSCRIPTION AGREEMENT dated as of September 29, 2020 (this “Agreement”) is by and between Digimarc Corporation, an
Oregon corporation (the “Company”), and TCM Strategic Partners L.P., a Delaware limited partnership (the “Purchaser”). Capitalized terms used but not defined herein have the meanings assigned to them in Exhibit
A. 
 The Purchaser desires to purchase from the Company, and the Company desires to issue and sell to the Purchaser, (i) 2,542,079
shares (the “Closing Shares”) of the Company’s common stock, par value $0.001 per share, and (ii) 16,970 shares (the “Preferred Shares” and together with the Closing Shares, “Purchased Shares”)
of the Company’s Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”), on the terms and subject to the conditions hereinafter set forth. 

In consideration of the premises and the mutual representations, warranties, covenants and agreements contained herein, and for other good and
valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: 
 ARTICLE I 

PURCHASE AND SALE OF PURCHASED SHARES 

Section 1.1 Purchase and Sale. On the terms and subject to the satisfaction or waiver of the conditions set forth in this
Agreement, at the Closings, the Purchaser shall purchase, and the Company shall issue and sell to the Purchaser, the Purchased Shares, free and clear of any liens (other than liens incurred by Purchaser or its Affiliates, restrictions arising under
applicable securities laws, or restrictions imposed by this Agreement, the Articles of Amendment (as defined below) or the Registration Rights Agreement) for an aggregate purchase price of $53,500,000. The aggregate purchase price represents a per
share price of $14.37 for the Closing Shares (and the aggregate purchase price for the Closing Shares, the “Closing Shares Purchase Price”) and a per share price of $1,000 for the Preferred Shares (and the aggregate purchase price
for the Preferred Shares, the “Preferred Shares Purchase Price”). The Series B Preferred Stock shall have the rights, powers, preferences and privileges set forth in the Articles of Amendment (the “Articles of
Amendment”) attached as Exhibit B. 
 Section 1.2 Closings. On the terms and subject to the satisfaction or
waiver of the conditions set forth in this Agreement, (i) the closing of the issuance, sale and purchase of the Closing Shares (the “Initial Closing”) shall take place remotely via the exchange of final documents and signature
pages, on the date of this Agreement, or such other time and place as the Company and the Purchaser may agree; and (ii) the closing of the issuance, sale and purchase of the Preferred Shares (the “Preferred Closing,” and
together with the Initial Closing, the “Closings”) shall take place remotely via the exchange of final documents and signature pages, on the date that is no later than one Business Day following the satisfaction or waiver of all of
the conditions set forth in Article V, or such other time and place as the Company and the Purchaser may agree. The date on which the Initial Closing is to occur is herein referred to as the “Initial Closing Date,” and the
date on which the Preferred Closing is to occur is herein referred to as the “Preferred Closing Date.” At the Initial Closing, (i) upon receipt by the Company of payment of the full Closing Shares Purchase Price by wire
transfer of immediately available funds to an account designated in writing by the Company (the “Designated Account”), the Company will deliver to the Purchaser evidence reasonably satisfactory to the Purchaser of the issuance of
the Closing Shares in the name of the Purchaser by book-entry on the books and records of the Company; (ii) each of the Company and the Purchaser shall deliver the Registration Rights Agreement, duly executed by the party; and (iii) the
Purchaser shall deliver to the Company a duly executed, valid, accurate and properly completed Internal 

 
Revenue Service Form W-9 certifying that such Purchaser is a U.S. person and that such Purchaser is not subject to backup withholding. At the Preferred
Closing, upon receipt by the Company of payment of the full Preferred Shares Purchase Price by wire transfer of immediately available funds to the Designated Account, the Company will deliver to the Purchaser evidence reasonably satisfactory to the
Purchaser of the issuance of the Preferred Shares in the name of the Purchaser by book-entry on the books and records of the Company. 

ARTICLE II 

REPRESENTATIONS AND WARRANTIES OF THE COMPANY 

The Company represents and warrants to the Purchaser that, except (a) as set forth in the SEC Documents filed by the Company with the SEC
on or after January 1, 2019 (other than disclosures in the “Risk Factors” or “Forward-Looking Statements” sections or similarly captioned sections of any such filings) and (b) as set forth on Exhibit D (the
“Disclosure Schedule”) (all such exceptions disclosed in the Disclosure Schedule being numbered to correspond to the applicable Section of this Article II, provided, however, that any such exception shall be
deemed to be disclosed with respect to each other representation or warranty to which the relevance of such exception is reasonably apparent on the face of such disclosure): 

Section 2.1 Organization and Power. 

(a)    The Company and each of its Subsidiaries is a corporation, limited liability company, partnership or other entity
validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation (as applicable) and has all requisite corporate, limited liability company, partnership or other entity power and authority to own or lease
its properties and to carry on its business as presently conducted and as proposed to be conducted. 
 (b)    The
Company and each of its Subsidiaries is duly licensed or qualified to do business as a foreign corporation, limited liability company, partnership or other entity in each jurisdiction wherein the character of its property or the nature of the
activities presently conducted by it, makes such qualification necessary, except where the failure to so qualify has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. 

Section 2.2 Authorization, Etc. 

(a)    The Company has all necessary corporate power and authority and has taken all necessary corporate action required
for the due authorization, execution, delivery and performance by the Company of this Agreement and the Registration Rights Agreement, and the consummation by the Company of the transactions contemplated hereby and thereby, the filing of the
Articles of Amendment with the Secretary of State of the State of Oregon and for the due authorization, issuance, sale and delivery of the Purchased Shares and the reservation, issuance and delivery of the Conversion Shares (as defined below). 

(b)    The authorization, execution, delivery and performance by the Company of this Agreement and the Registration Rights
Agreement, and the consummation by the Company of the transactions contemplated hereby and thereby, including the filing of the Articles of Amendment and the issuance of the Purchased Shares and the Conversion Shares do not and will not:
(a) violate or result in the breach of any provision of the Articles of Incorporation or Bylaws of the Company; or (b) with such exceptions that have not had, and would not reasonably be expected to have, individually or in the aggregate,
a Material Adverse Effect: (i) violate any provision of, constitute a breach of, or default under, any judgment, order, writ, or decree applicable to the Company or any of its Subsidiaries or any material

  
 -2- 

 
mortgage, credit agreement or contract to which the Company or any of its Subsidiaries is a party; (ii) violate any provision of, constitute a breach of, or default under, any applicable
state, federal or local law, rule or regulation; or (iii) result in the creation of any lien upon any assets of the Company or any of its Subsidiaries or the suspension, revocation or forfeiture of any franchise, permit or license granted by a
governmental authority to the Company or any of its Subsidiaries, other than liens under federal or state securities laws. This Agreement has been, and the Registration Rights Agreement, at the Closing will be, duly executed and delivered by the
Company. Assuming due execution and delivery thereof by each of the other parties hereto or thereto, this Agreement and the Registration Rights Agreement will each be a valid and binding obligation of the Company enforceable against the Company in
accordance with its terms, except as such enforceability may be limited by applicable laws relating to bankruptcy, insolvency, reorganization, moratorium or other similar legal requirement relating to or affecting creditors’ rights generally
and except as such enforceability is subject to general principles of equity (regardless of whether enforceability is considered in a proceeding in equity or at law). The Company has taken all appropriate actions so that the restrictions on business
combinations contained in Sections 60.825 through 60.845 of the OBCA will not apply with respect to or as a result of the issuance of the Purchased Shares (or the Conversion Shares) to the Purchaser or the Transfer thereof to its Permitted
Transferees in accordance with this Agreement without any further action on the part of the shareholders or the Board of Directors. 

Section 2.3 Government Approvals. No consent, approval or authorization of, or filing with, any court or governmental authority is
or will be required on the part of the Company in connection with the execution, delivery and performance by the Company of this Agreement and the Registration Rights Agreement, or in connection with the issuance of the Purchased Shares or the
Conversion Shares, except for (a) the filing of the Articles of Amendment with the Secretary of State of the State of Oregon; (b) those which have already been made or granted; (c) the filing of a Form D and current report on Form 8-K with the SEC; (d) filings with applicable state securities commissions; or (e) the listing of the Closing Shares and the Conversion Shares with the Nasdaq Stock Market. 

Section 2.4 Authorized and Outstanding Stock. 

(a)    The authorized capital stock of the Company consists of 50,000,000 shares of common stock, $.001 par value per
share (“Common Stock”) and 2,500,000 shares of preferred stock, par value $.001 per share (“Preferred Stock”). Ten Thousand (10,000) shares of Preferred Stock are designated as Series A Redeemable Nonvoting
Preferred Stock, and 500,000 shares of Preferred Stock are designated as Series R Participating Cumulative Preferred Stock. 

(b)    As of September 25, 2020, (i) 12,774,269 shares of Common Stock were issued and outstanding, (ii) 10,000
shares of Series A Redeemable Nonvoting Preferred Stock were issued and outstanding, and (iii) 1,276,263 shares of Common Stock were reserved for issuance pursuant to the Company’s stock plans, of which 802,564 shares remained available for
future grants. Upon the filing of the Articles of Amendment with the Secretary of State of the State of Oregon, 16,970 shares will be designated as the Series B Preferred Stock. 

(c)    All of the issued and outstanding shares of Common Stock of the Company are, and when issued in accordance with the
terms hereof, the Purchased Shares will be, duly authorized and validly issued and fully paid and non-assessable. The shares of Common Stock issuable upon conversion of the Purchased Shares (the
“Conversion Shares” and together with the Closing Shares, the “Shares”) have been reserved for issuance and, when issued upon conversion thereof in accordance with the terms of the Articles of Amendment in
accordance with their terms and upon obtaining Shareholder Approval will be validly issued and fully paid and non-assessable and will not be subject to any preemptive right or any restrictions on transfer
under applicable law or any contract to which the Company is a party, other than those under applicable state and federal securities and antitakeover laws, this Agreement and the 

  
 -3- 

 
Registration Rights Agreement. When issued in accordance with the terms hereof, the Purchased Shares and the Conversion Shares will be free and clear of all liens (other than liens incurred by
Purchaser or its Affiliates, restrictions arising under applicable securities laws, or restrictions imposed by this Agreement, the Articles of Amendment or the Registration Rights Agreement). 

(d)    Except as otherwise expressly described in this Agreement: (i) no subscription, warrant, option, convertible
security or other right issued by the Company to purchase or acquire any shares of capital stock of the Company is authorized or outstanding; (ii) there is not any commitment of the Company to issue any subscription, warrant, option,
convertible security or other such right or to issue or distribute to holders of any shares of its capital stock; (iii) the Company has no obligation to purchase, redeem or otherwise acquire any shares of its capital stock or to pay any
dividend or make any other distribution in respect thereof; and (iv) there are no agreements between the Company and any holder of its capital stock relating to the acquisition, disposition or voting of the capital stock of the Company. No
person or entity is entitled to any preemptive right granted by the Company with respect to the issuance of any capital stock of the Company. 

Section 2.5 Subsidiaries. The Company’s Subsidiaries consist of all the entities listed on Exhibit 21.1 to the Company’s
Form 10-K for the year ended December 31, 2019. Except as described in the SEC Documents, the Company, directly or indirectly, owns of record and beneficially, free and clear of all liens, all of the
issued and outstanding capital stock or equity interests of each of its Subsidiaries. All of the issued and outstanding capital stock or equity interests of the Company’s Subsidiaries has been duly authorized and validly issued, and in the case
of corporations, is fully paid and non-assessable. Except as described in the SEC Documents, there are no outstanding rights, options, warrants, preemptive rights, conversion rights, rights of first refusal or
similar rights for the purchase or acquisition from any of the Company’s Subsidiaries of any securities of such Subsidiaries nor are there any commitments to issue or execute any such rights, options, warrants, preemptive rights, conversion
rights or rights of first refusal. 
 Section 2.6 Private Placement. Assuming the accuracy of the representations and warranties
of the Purchaser set forth in Section 3.4 (Investment Representations), the offer and sale of the Purchased Shares pursuant to this Agreement will be exempt from the registration requirements of the Securities Act. 

Section 2.7 SEC Documents; Financial Information. Since January 1, 2019, the Company has timely filed (a) all annual and
quarterly reports and proxy statements (including all amendments, exhibits and schedules thereto) and (b) all other reports and other documents (including all amendments, exhibits and schedules thereto), in each case required to be filed by the
Company with the SEC pursuant to the Exchange Act and the Securities Act except, in the case of clause (b), where the failure to file has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect. As of their respective filing dates, such SEC Documents complied in all material respects with the requirements of the Securities Act, the Exchange Act and the rules and regulations of the SEC thereunder applicable to such SEC Documents, and
as of their respective dates none of the SEC Documents contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Documents (the “Financial Statements”) comply as of their respective dates in all material respects with
applicable accounting requirements and the rules and regulations of the SEC with respect thereto (except as may be indicated in the notes thereto or, in the case of the unaudited statements, as permitted by Form
10-Q promulgated by the SEC), and present fairly in all material respects as of their respective dates the consolidated financial position of the Company and its Subsidiaries as at the dates thereof and the
consolidated results of their operations and their consolidated cash flows for each of the respective periods, all in conformity with GAAP, applied on a consistent basis during the periods involved (except as may be indicated in such Financial
Statements or the notes thereto). The Company satisfies the 

  
 -4- 

 
“registrant requirements” for use of Form S-3 set forth in General Instruction I.A to Form S-3
promulgated by the SEC. The Company and its Subsidiaries do not have any liabilities or obligations that would be required under GAAP, as in effect on the date of this Agreement, to be reflected on a consolidated balance sheet of the Company
(accrued, absolute, contingent or otherwise), other than liabilities or obligations (i) reflected on, reserved against, or disclosed in the notes to, the Company’s consolidated balance sheet as of June 30, 2020 (the “Balance
Sheet Date”) included in the SEC documents, (ii) that were incurred in the ordinary course of business after the Balance Sheet Date, (iii) liabilities as contemplated by the Transaction Documents or otherwise incurred in
connection with the Transaction Documents or the transactions contemplated hereby, or (iv) that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 

Section 2.8 Internal Control Over Financial Reporting. The Company has disclosed, based on its most recent evaluation prior to the
date hereof, to the Company’s outside auditors and the Audit Committee of the Board of Directors (a) any significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting (as defined
in Rule 13a-15(f) under the Exchange Act) that are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information and (b) any fraud,
whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting. 

Section 2.9 Disclosure Controls and Procedures. The Company has established and maintains disclosure controls and procedures (as
such term is defined in Rule 13a-15 and 15d-15 under the Exchange Act) that are designed to provide reasonable assurance that material information relating to the
Company, including its Subsidiaries, that is required to be disclosed by the Company in the reports that it furnishes or files under the Exchange Act is reported within the time periods specified in the rules and forms of the SEC and that such
material information is communicated to the Company’s management to allow timely decisions regarding required disclosure. 

Section 2.10 Litigation. There is no litigation or governmental proceeding pending or, to the knowledge of the Company, threatened
in writing, against the Company or any of its Subsidiaries or affecting any of the business, operations, properties or assets of the Company or any of its Subsidiaries which would reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect. Neither the Company nor any of its Subsidiaries is in default with respect to any order, writ, injunction, decree, ruling or decision of any court, commission, board or other government agency that is expressly applicable to
the Company or any of its Subsidiaries which would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. 

Section 2.11 Compliance with Laws; Permits. The Company and its Subsidiaries are in compliance with all applicable laws, except as
has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. The Company and its Subsidiaries possess all permits and licenses of governmental authorities that are required to conduct their
business, except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. 

Section 2.12 Taxes. The Company and each of its Subsidiaries has filed all Tax Returns required to be filed within the applicable
periods for such filings (with due regard to any extension) and has timely paid all Taxes required to be paid, except for any such failures to file or pay that have not had, and would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect. The Company is not a United States real property holding corporation within the meaning of Section 897 of the Code (“USRPHC”). 

  
 -5- 

 Section 2.13 Employee Matters. Except where the failure to comply has not had,
and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, the Company and its Subsidiaries are in compliance with all applicable laws relating to labor, employment, fair employment practices, terms
and conditions of employment, and wages and hours, and with the terms of the ERISA Documents, and each such ERISA Document is in compliance with all applicable requirements of ERISA. No material labor dispute with the employees of the Company or any
of its Subsidiaries exists, or to the knowledge of the Company, is imminent. 
 Section 2.14 Environmental Matters. The Company
and its Subsidiaries are in compliance with all applicable Requirements of Environmental Law and required Environmental Permits, except, in each case, where the failure to comply has not had, and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect. The Company and its Subsidiaries have not received within the past three years any written notice from any governmental authority of any violation or alleged violation of any Requirements
of Environmental Law or Environmental Permit in connection with their respective properties, except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. 

Section 2.15 Customer Matters. Except as has not had, and would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, the Company has not received, since June 30, 2020, any written notice that any of its customers has ceased, or intends to cease using its goods or services, or to otherwise terminate or reduce its
relationship with the Company. 
 Section 2.16 Title to Properties. Except as disclosed in the SEC Documents, the Company and
its Subsidiaries have good and marketable title to all real properties and all other properties and assets owned by them, in each case free from liens, encumbrances and defects that would materially affect the value thereof or materially interfere
with the use made or currently planned to be made thereof by them; and except as disclosed in the SEC Documents, the Company and its Subsidiaries hold any leased real or personal property under valid and enforceable leases with no exceptions that
would materially interfere with the use made or currently planned to be made thereof by them. 
 Section 2.17 Intellectual
Property. The Company owns or possesses sufficient rights to use all Intellectual Property which is necessary to conduct its businesses as currently conducted, except where the failure to own or possess such sufficient rights would not
reasonably be expected to result, either individually or in the aggregate, in a Material Adverse Effect. The Company has not received, since June 30, 2020, any written notice of, and has no actual knowledge of, any infringement of or conflict
with asserted rights of others with respect to any Intellectual Property which, either individually or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would reasonably be expected to have a Material Adverse Effect.
For the purposes of this agreement, “Intellectual Property” means all of the following: (a) patents, patent applications, patent disclosures and inventions (whether or not patentable and whether or not reduced to practice); (b)
trademarks, service marks, trade dress, trade names, corporate names, logos, slogans and Internet domain names, together with all goodwill associated with each of the foregoing; (c) copyrights and copyrightable works; (d) registrations,
applications and renewals for any of the foregoing; and (e) proprietary computer software (including but not limited to data, data bases and documentation). 

Section 2.18 Subsequent Events. Since June 30, 2020, except for the execution and performance of this Agreement, there has
been no Material Adverse Effect. 
 Section 2.19 Insurance Coverage. The Company and its Subsidiaries maintain in full force and
effect insurance coverage that is customary for comparably situated companies for the business being conducted and properties owned or leased by the Company and its Subsidiaries, and the Company reasonably believes such insurance coverage to be
adequate against all liabilities, claims and risks against which it is customary for comparably situated companies to insure. 

  
 -6- 

 Section 2.20 Transactions with Affiliates. Except as disclosed in the SEC
Documents, none of the officers or directors of the Company and, to the knowledge of the Company, none of the employees of the Company is presently a party to any transaction with the Company or any of its Subsidiaries (other than as holders of
stock options and/or warrants, and for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or
from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director,
trustee or partner, in each case that would require disclosure in an SEC filing made by the Company (if such filing were being made on the date hereof) pursuant to Item 404 of Regulation S-K under the 1934
Act. 
 Section 2.21 Registration Rights. Except as provided in this Agreement or the Registration Rights Agreement or disclosed
in the SEC Documents, the Company has not granted any rights to register under the Securities Act any of its presently outstanding securities or any of its securities that may be issued subsequently. 

Section 2.22 Investment Company Act. The Company is not, and immediately after giving effect to the sale of the Purchased Shares
in accordance with this Agreement and the application of the proceeds thereof will not be required to be registered as, an “investment company” or a company “controlled” by an “investment company,” within the meaning of
the Investment Company Act. 
 Section 2.23 Nasdaq. As of the date hereof, the Company’s Common Stock is listed on the
Nasdaq Stock Market, and no event has occurred, and the Company is not aware of any event that is reasonably likely to occur, that would result in the Common Stock being delisted from the Nasdaq Stock Market. The Company is in compliance with
applicable continued listing requirements of the Nasdaq Stock Market. 
 Section 2.24 No Brokers or Finders. No Person has or
will have, as a result of the transactions contemplated by this Agreement, any right, interest or claim against or upon the Company, any of its Subsidiaries or the Purchaser for any commission, fee or other compensation as a finder or broker because
of any act of the Company or any of its Subsidiaries. 
 Section 2.25 Illegal Payments; FCPA Violations. Except as has not had,
and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, since January 1, 2019, none of the Company, any of its Subsidiaries or, to the knowledge of the Company, any officer, director, employee,
agent, representative or consultant acting on behalf of the Company or any of its Subsidiaries (and only in their capacities as such) has, in connection with the business of the Company: (a) unlawfully offered, paid, promised to pay, or
authorized the payment of, directly or indirectly, anything of value, including money, loans, gifts, travel, or entertainment, to any Government Official with the purpose of (i) influencing any act or decision of such Government Official in his
or her official capacity; (ii) inducing such Government Official to perform or omit to perform any activity in violation of his or her legal duties; (iii) securing any improper advantage; or (iv) inducing such Government Official to
influence or affect any act or decision of such Governmental Entity, except, with respect to the foregoing clauses (i) through (iv), as permitted under the U.S. Foreign Corrupt Practices Act (as defined below) or other applicable law;
(b) made any illegal contribution to any political party or candidate; (c) made, offered or promised to pay any unlawful bribe, payoff, influence payment, kickback, unlawful rebate, or other similar unlawful payment of any nature, directly
or indirectly, in connection with the business of the Company, to any person, including any supplier or customer; (d) knowingly established or maintained any unrecorded fund or asset or made any false entry on any book or record of the Company

  
 -7- 

 
or any of its Subsidiaries for any purpose; or (e) otherwise violated the U.S. Foreign Corrupt Practices Act of 1977, as amended (the “U.S. Foreign Corrupt Practices Act”),
the UK Bribery Act 2010, as amended, or any other applicable anti-corruption or anti-bribery law. 
 Section 2.26 Economic
Sanctions. Except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, the Company is not in contravention of any sanction, and has not engaged in any conduct sanctionable,
under U.S. economic sanctions laws, including applicable laws administered and enforced by the U.S. Department of the Treasury’s Office of Foreign Assets Control, 31 C.F.R. Part V, the Iran Sanctions Act, as amended, the Comprehensive Iran
Sanctions, Accountability and Divestment Act, as amended, the Iran Threat Reduction and Syria Human Rights Act, as amended, the Iran Freedom and Counter-Proliferation Act of 2012, as amended, and any executive order issued pursuant to any of the
foregoing. 
 Section 2.27 No Additional Representations. Except for the representations and warranties made by the Company in
this Article II, neither the Company nor any other Person makes any express or implied representation or warranty with respect to the Company or any Subsidiaries or their respective businesses, operations, assets, liabilities, employees,
employee benefit plans, conditions or prospects, and the Company hereby disclaims any such other representations or warranties. In particular, without limiting the foregoing disclaimer, neither the Company nor any other Person makes or has made any
representation or warranty to the Purchaser, or any of its Affiliates or representatives, with respect to (a) any financial projection, forecast, estimate, budget or prospect information relating to the Company or any of its Subsidiaries or
their respective business, or (b) any oral or written information presented to the Purchaser or any of its Affiliates or representatives in the course of their due diligence investigation of the Company, the negotiation of this Agreement or in
the course of the transactions contemplated hereby. Notwithstanding anything to the contrary herein, nothing in this Agreement shall limit the right of the Purchaser and its Affiliates to rely on the representations, warranties, covenants and
agreements expressly set forth in this Agreement, nor will anything in this Agreement operate to limit any claim by the Purchaser for intentional and actual fraud solely with respect to the representations and warranties made by the Company is this
Article II. 
 ARTICLE III 

REPRESENTATIONS AND WARRANTIES OF THE PURCHASER 

The Purchaser represents and warrants to the Company that: 

Section 3.1 Organization and Power. The Purchaser is a limited partnership duly formed, validly existing and in good standing
under the laws of the jurisdiction of its formation and has all requisite limited partnership or other entity power and authority to own its properties and to carry on its business as presently conducted. 

Section 3.2 Authorization, Etc. 

(a)    The Purchaser has all necessary limited partnership or other entity power and authority and the Purchaser and its
general partner have taken all necessary partnership or other entity action required for the due authorization, execution, delivery and performance by the Purchaser of this Agreement and the Registration Rights Agreement and the consummation by the
Purchaser of the transactions contemplated hereby and thereby. 
 (b)    The authorization, execution, delivery and
performance by the Purchaser of this Agreement and the Registration Rights Agreement, and the consummation by the Purchaser of the transactions contemplated hereby and thereby do not and will not: (a) violate or result in the breach of any

  
 -8- 

 
provision of the certificate of limited partnership and limited partnership agreement (or similar organizational document) of the Purchaser; or (b) with the exceptions that are not
reasonably likely to have, individually or in the aggregate, a material adverse effect on its ability to perform its obligations under this Agreement and the Registration Rights Agreement: (i) violate any provision of, constitute a breach of,
or default under, any judgment, order, writ, or decree applicable to the Purchaser or any material contract to which the Purchaser is a party; or (ii) violate any provision of, constitute a breach of, or default under, any applicable state,
federal or local law, rule or regulation. This Agreement has been, and the Registration Rights Agreement will, at the Closing be, duly executed and delivered by the Purchaser. Assuming due execution and delivery thereof by the other parties hereto
or thereto, this Agreement and the Registration Rights Agreement will each be a valid and binding obligation of the Purchaser enforceable against the Purchaser in accordance with its terms, except as the enforceability may be limited by applicable
laws relating to bankruptcy, insolvency, reorganization, moratorium or other similar legal requirement relating to or affecting creditors’ rights generally and except as the enforceability is subject to general principles of equity (regardless
of whether enforceability is considered in a proceeding in equity or at law). 
 Section 3.3 Government Approvals. No consent,
approval, license or authorization of, or filing with, any court or governmental authority is or will be required on the part of the Purchaser in connection with the execution, delivery and performance by the Purchaser of this Agreement and the
Registration Rights Agreement, except for: (a) those which have already been made or granted; (b) the filing with the SEC of a Schedule 13D or Schedule 13G and a Form 3 to report the Purchaser’s ownership of the Purchased Shares; or
(c) those where the failure to obtain such consent, approval or license would not have a material adverse effect on the ability of the Purchaser to perform its obligations hereunder. 

Section 3.4 Investment Representations. 

(a)    The Purchaser is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D
promulgated under the Securities Act. 
 (b)    The Purchaser has been advised by the Company that the Purchased Shares
have not been registered under the Securities Act, that the Purchased Shares will be issued on the basis of the statutory exemption provided by Section 4(a)(2) under the Securities Act or Regulation D promulgated thereunder, or both, relating
to transactions by an issuer not involving any public offering and under similar exemptions under certain state securities laws, that this transaction has not been reviewed by, passed on or submitted to any federal or state agency or self-regulatory
organization where an exemption is being relied upon, and that the Company’s reliance thereon is based in part upon the representations made by the Purchaser in this Agreement and the Registration Rights Agreement. The Purchaser acknowledges
that it has been informed by the Company of, or is otherwise familiar with, the nature of the limitations imposed by the Securities Act and the rules and regulations thereunder on the transfer of securities. 

(c)    The Purchaser is purchasing the Purchased Shares for its own account and not with a view to, or for sale in
connection with, any distribution thereof in violation of federal or state securities laws. 
 (d)    By reason of its
business or financial experience, the Purchaser has the capacity to protect its own interest in connection with the transactions contemplated hereunder. 

(e)    The Company has provided to the Purchaser all documents and information that the Purchaser has requested relating
to an investment in the Company. The Purchaser recognizes that investing in the Company involves substantial risks, and has taken full cognizance of and understands all of the risk factors related to the acquisition of the Purchased Shares. The
Purchaser has carefully 

  
 -9- 

 
considered and has, to the extent it believes such discussion necessary, discussed with the Purchaser’s professional legal, tax and financial advisers the suitability of an investment in the
Company, and the Purchaser has determined that the acquisition of the Purchased Shares is a suitable investment for the Purchaser. The Purchaser has not relied on the Company for any tax or legal advice in connection with the purchase of the
Purchased Shares. In evaluating the suitability of an investment in the Company, the Purchaser has not relied upon any representations or other information (other than the representations and warranties of the Company set forth in Article
II). 
 Section 3.5 No Prior Ownership. Prior to the Closing, the Purchaser does not have record or beneficial ownership
(within the meaning of Rule 13d-3 under the Exchange Act) of any shares of the Company’s Common Stock. 

Section 3.6 No Brokers or Finders. No Person has or will have, as a result of the transactions contemplated by this Agreement, any
right, interest or claim against or upon the Company, any of its Subsidiaries or any Purchaser for any commission, fee or other compensation as a finder or broker because of any act by the Purchaser. 

Section 3.7 ERISA. The Purchaser does not hold, and no part of the funds used by the Purchaser to acquire any Purchased Shares
constitutes, “plan assets” (within the meaning of the ERISA Regulations). The Purchaser is not (a) an “employee benefit plan” that is subject to Part 4 of Title I of ERISA, (b) a “plan” to which
Section 4975 of the Code applies or (c) an entity whose underlying assets could be deemed to include “plan assets” by reason of an employee benefit plan’s investment in such entity. 

Section 3.8 No Additional Representations. The Purchaser acknowledges and agrees, on behalf of itself and its Affiliates, that,
except for the representations and warranties contained in Article II, neither the Company nor any other Person, makes any express or implied representation or warranty with respect to the Company, its Subsidiaries or their respective businesses,
operations, assets, liabilities, employees, employee benefit plans, conditions or prospects, and the Purchaser, on behalf of itself and its Affiliates, hereby disclaims reliance upon any such other representations or warranties. In particular,
without limiting the foregoing disclaimer, the Purchaser acknowledges and agrees, on behalf of itself and its Affiliates, that neither the Company nor any other Person, makes or has made any representation or warranty with respect to, and the
Purchaser, on behalf of itself and its Affiliates, hereby disclaims reliance upon (a) any financial projection, forecast, estimate, budget or prospect information relating to the Company, its Subsidiaries or their respective business, or
(b) without limiting the representations and warranties made by the Company in Article II, any information presented to the Purchaser or any of its Affiliates or representatives in the course of their due diligence investigation of the Company,
the negotiation of this Agreement or in the course of the transactions contemplated hereby. To the fullest extent permitted by applicable law, without limiting the representations and warranties contained in Article II, neither the Company nor any
of its Subsidiaries shall have any liability to any Purchaser or its Affiliates or representatives on any basis (including in contract or tort, under federal or state securities laws or otherwise) based upon any other representation or warranty,
either express or implied, included in any information or statements (or any omissions therefrom) provided or made available by the Company or its Subsidiaries to Purchaser or its Affiliates or representatives in the course of their due diligence
investigation of the Company, the negotiation of this Agreement or in the course of the transactions contemplated by this Agreement. 

  
 -10- 

 ARTICLE IV 

COVENANTS OF THE PARTIES 

Section 4.1 Board of Directors. 

(a)    For so long as the Purchaser and its Affiliates continue to have record and beneficial ownership (within the
meaning of Rule 13d-3 under the Exchange Act) of Shares that constitute at least five percent (5%) of the outstanding Common Stock of the Company, the Company shall cause the Principal to be elected or
appointed to the Board of Directors (the Principal in such capacity, the “Purchaser Designee”). If the Purchaser has the right to designate the Purchaser Designee in a given year, the Company shall, at the annual meeting of the
shareholders of the Company during such year, nominate the Purchaser Designee for election to the Board of Directors and cause the Purchaser Designee to be elected or appointed to the Board of Directors; provided, however, that the
Purchaser Designee shall continue to comply in all material respects with the corporate governance principles and policies of the Company as in effect from time to time to the extent such compliance is required from all of the other director
appointees, nominees or applicants. In the event that the Purchaser and its Affiliates cease to hold the minimum percentage of the outstanding Common Stock that entitles it to designate the Purchaser Designee as provided above, if requested by the
Board of Directors, the Purchaser shall use reasonable best efforts to have such Purchaser Designee resign as a director. As a pre-condition to the nomination of Purchaser Designee, Purchaser Designee shall
execute and deliver to the Board of Directors an irrevocable letter of resignation to be deemed tendered at the time the Purchaser is required to use reasonable best efforts to have the Purchaser Designee resign. For the avoidance of doubt, in the
event that the Purchaser’s and its Affiliates’ holdings of Common Stock drops below such minimum percentage, the Purchaser will not regain the right to nominate the Purchaser Designee through the subsequent acquisition of additional
Company Securities. 
 (b)    Subject to applicable legal requirements and stock exchange rules, for as long as the
Purchaser Designee serves on the Board of Directors, the Purchaser Designee shall be a member of any committee or any executive committee formed by the Board of Directors other than any committee formed for the purposes of considering any
transaction with the Purchaser or its Affiliates. 
 (c)    The Purchaser Designee shall be entitled to
(i) reimbursement of expenses and indemnification in the same manner and to the same extent as the other members of the Board of Directors, in accordance with the Company’s organizational documents, and (ii) compensation in the same
manner and to the same extent as the other members of the Board of Directors. 
 (d)    The Company shall maintain from
financially sound and reputable insurers directors and officers insurance with coverage customary for similarly situated companies, which shall include coverage of the Purchaser Designee. 

(e)    The Company acknowledges that the Purchaser Designee may have certain rights to indemnification, advancement of
expenses and/or insurance provided by Purchaser and/or its respective Affiliates (collectively, the “Purchaser Indemnitors”). The Company hereby agrees that, with respect to a claim by the Purchaser Designee for indemnification
arising out the Purchaser Designee’s service as a director of the Company, (1) it is the indemnitor of first resort (i.e., its obligations to the Purchaser Designee with respect to indemnification, advancement of expenses and/or
insurance (which obligations shall be the same as, but in no event greater than, any such obligations to members of the Board of Directors) are primary and any obligation of the Purchaser Indemnitors to advance expenses or to provide indemnification
for the same expenses or liabilities incurred by the Purchaser Designee are secondary), and (2) the Purchaser Indemnitors shall have a right of contribution and/or be subrogated to the extent of such advancement or payment to all of the rights
of recovery of the Purchaser Designee against the Company. 
 Section 4.2 Restrictions on Transfer. 

(a)    During the period commencing on the Initial Closing Date and continuing until the date that is the one year
anniversary of the Preferred Closing Date (or the Initial Closing Date in the 

  
 -11- 

 
event that the Preferred Closing does not occur), the Purchaser shall not Transfer any of the Shares to any Person without the consent of the Company; provided, however, that,
without the consent of the Company, the Purchaser may Transfer Shares (i) to a Permitted Transferee of the Purchaser that agrees to be bound by the terms of this Section 4.2 and Section 4.3
pursuant to a written agreement in form and substance reasonably satisfactory to the Company; (ii) pursuant to a tender or exchange offer, merger, consolidation, division, acquisition, reorganization or recapitalization involving the Company
that has been recommended or approved by a majority of the Board; or (iii) following the date the Company commences a voluntary case under Title 11 of the United States Bankruptcy Code or any other similar insolvency laws. 

(b)    During the period commencing on the Preferred Closing Date and continuing until the date that is the six-month anniversary of the Preferred Closing Date, the Purchaser shall not Transfer any of the Preferred Shares to any Person without the consent of the Company; provided, however, that,
(i) during the period commencing on the six-month anniversary of the Preferred Closing Date and continuing until the one-year anniversary of the Preferred Closing
Date, as a condition to transfer of the Preferred Shares, the transferee must agree to be bound by the terms of this Section 4.2 and Section 4.3 pursuant to a written agreement in form and
substance reasonably satisfactory to the Company, and (ii) without the consent of the Company, the Purchaser may Transfer Preferred Shares at any time (A) to a Permitted Transferee of the Purchaser that agrees to be bound by the terms of
this Section 4.2 and Section 4.3 pursuant to a written agreement in form and substance reasonably satisfactory to the Company; (B) pursuant to a tender or exchange offer, merger,
consolidation, division, acquisition, reorganization or recapitalization involving the Company that has been recommended or approved by a majority of the Board of Directors; or (C) following the date the Company commences a voluntary case under
Title 11 of the United States Bankruptcy Code or any other similar insolvency laws. 
 (c)    In any event, Restricted
Securities shall not be Transferred except upon the conditions specified in Section 4.3, which conditions are intended to ensure compliance with the provisions of the Securities Act. Any attempted Transfer in violation of
this Section 4.2 shall be void ab initio. 
 Section 4.3 Restrictive Legends. 

(a)    Each certificate representing the Purchased Shares or Conversion Shares shall be stamped or otherwise imprinted
with a legend in substantially the following form (in addition to any legend required under applicable state securities laws): 
 “THE
OFFER AND SALE OF THIS SECURITY AND THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THIS SECURITY, IF ANY, HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND THIS SECURITY AND
SUCH SHARES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED EXCEPT (A) PURSUANT TO A REGISTRATION STATEMENT THAT IS EFFECTIVE UNDER THE SECURITIES ACT; OR (B) PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.” 
 (b)    In addition, for so long as the Purchased Shares or
Conversion Shares are subject to the restrictions set forth in Section 4.2, each certificate representing the Purchased Shares or Conversion Shares shall be stamped or otherwise imprinted with a legend in substantially the
following form: 

  
 -12- 

 “THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER
SET FORTH IN A SUBSCRIPTION AGREEMENT. THE COMPANY WILL MAIL TO THE HOLDER OF THIS CERTIFICATE A COPY OF SUCH SUBSCRIPTION AGREEMENT, AS IN EFFECT ON THE DATE OF MAILING, WITHOUT CHARGE, PROMPTLY AFTER RECEIPT OF A WRITTEN REQUEST THEREFOR.”

 (c)    The Purchaser consents to the Company making a notation on its records and giving instructions to any transfer
agent of the Purchased Shares or the Conversion Shares in order to implement the restrictions on transfer set forth in this Section 4.3. 

(d)    Upon the request of the Purchaser, the restrictive legends set forth in this Section 4.3
shall be removed if in compliance with this Agreement, including Section 4.2, (i) the Purchased Shares and/or Conversion Shares are sold or transferred pursuant to Rule 144, or (ii) the Purchased Shares and/or
Conversion Shares are eligible for sale under Rule 144, without the requirement for the Company to be in compliance with the current public information required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable) as to such securities and
without volume or manner-of-sale restrictions. Following Rule 144 becoming available for the resale of the Purchased Shares and/or Conversion Shares, without the
requirement for the Company to be in compliance with the current public information required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable) as to the Purchased Shares and/or Conversion Shares and without volume or manner-of-sale restrictions, subject to Section 4.2, the Company, upon the written request of the Purchaser, shall instruct its transfer agent to
remove the legend from the Purchased Shares and/or Conversion Shares and shall cause its counsel to issue any legend removal opinion required by the transfer agent. Any fees (with respect to the Company or the transfer agent, Company counsel or
otherwise) associated with the issuance of such opinion or the removal of such legend shall be borne by the Company. 

(e)    The Company shall cooperate, in accordance with reasonable and customary business practices, with any and all
transfers, whether by direct or indirect sale, assignment, award, confirmation, distribution, bequest, donation, trust, pledge, encumbrance, hypothecation or other transfer or disposition, for consideration or otherwise, whether voluntarily or
involuntarily, by operation of law or otherwise, by the Purchaser or any of their respective successors and assigns of the Purchased Shares and Conversion Shares and other shares of Common Stock and/or Preferred Stock such party may beneficially own
prior to or subsequent to the date hereof; provided that each such transfer is being made in accordance with applicable law and all applicable contractual restrictions, including pursuant to this Agreement and the Registration Rights Agreement, if
applicable. 
 Section 4.4 Standstill. The Purchaser agrees that until the date that is the one year anniversary of the
Preferred Closing Date (or the Initial Closing Date in the event that the Preferred Closing does not occur), without the prior written consent of the Company, it will not at any time, nor will it cause or permit any of its Affiliates to:
(a) effect or knowingly seek, publicly offer or propose to effect, or announce any intention to effect or cause or participate in or in any way knowingly assist, facilitate or encourage any other person to effect or seek, offer or propose
(whether publicly or otherwise) to effect or participate in, (i) any acquisition of any securities (or beneficial ownership thereof), or rights or options to acquire any securities (or beneficial ownership thereof), or any assets, indebtedness
or businesses of the Company or its Subsidiaries, or (ii) any tender or exchange offer, merger or other business combination involving the Company or its Subsidiaries or assets of the Company or its Subsidiaries constituting a significant
portion of the consolidated assets of the Company and its Subsidiaries; (b) form, join or in any way participate in a “group” (as defined under the Exchange Act) with respect to the foregoing; (c) take any action which would or
would reasonably be expected to force the Company to make a public announcement regarding any of the types of matters set forth in clause (a) above; or (d) enter into any discussions or arrangements with any third party with respect to any
of the foregoing; it being understood that nothing in this Section 4.4 shall (1) restrict or prohibit the Purchaser Designee from taking any action, or refraining from taking any action, which the Purchaser Designee
determines, in the Purchaser Designee’s reasonable discretion, is necessary to fulfill the Purchaser Designee’s fiduciary duties as a 

  
 -13- 

 
member of the Board of Directors; (2) restrict or prohibit the Purchaser’s acquisition of Common Stock, if after giving effect to such transaction, Purchaser and its Affiliates
beneficially own (within the meaning of Rule 13d-3 under the Exchange Act), in the aggregate, a number of shares of Common Stock that is less than twenty-seven and
one-half percent (27.5%) of the total shares of Common Stock outstanding, plus (I) any additional Common Stock acquired through the accretion of dividends thereon and on the Series B Preferred Stock and
any dividends payable in any other security and (II) any Common Stock issued to the Purchaser Designee in the form of director compensation; (3) restrict or prohibit Purchaser from engaging in discussions that may be deemed to encourage a
passive investment in the Company’s stock and which would not, under any circumstances, reasonably be expected to result in an acquisition that would require a filing by any participant of a beneficial ownership report on Schedule 13D,
(4) restrict or prohibit the Purchaser from participating in a tender or exchange offer, merger, consolidation, division, acquisition, reorganization or recapitalization involving the Company that has been recommended or approved by a majority
of the Board of Directors without violation of the terms of this Section 4.4, or (5) restrict or prohibit the Purchaser from any action set forth in this Section 4.4 following the date the
Company commences a voluntary case under Title 11 of the United States Bankruptcy Code or any other similar insolvency laws. 

Section 4.5 Hedging Transactions. At any time that Purchaser Designee is serving on the Board of Directors, the Purchaser agrees
that it will not enter into any Hedging Transactions to the extent directors of the Company are prohibited from entering into such Hedging Transactions pursuant to a policy applicable to all directors of the Company. 

Section 4.6 Use of Proceeds. The Company shall use the proceeds from the sale of the Purchased Shares (a) to fund working
capital, (b) to pay for the fees and expenses incurred by the Company in connection with the transactions contemplated by this Agreement and the Registration Rights Agreement, and (c) general corporate purposes. 

Section 4.7 USRPHC Status. At the Purchaser’s request from time to time while the Purchaser owns an equity interest in the
Company, the Company shall use commercially reasonable efforts to determine as promptly as practicable whether it is a USRPHC and shall promptly notify the Purchaser in writing of its determination of its status as a USRPHC (and if in connection
with a sale, shall promptly provide to the Purchaser a statement in accordance with Treasury Regulations Section 1.897-2(h)(1) where it determines the interest being sold is not a United States real
property interest within the meaning of Section 897 of the Code). 
 Section 4.8 Financial Statements and Other
Information. 
 (a)    Subject to Section 4.8(c), and for so long as the Purchaser holds
record and beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act) of more than five percent (5%) of the outstanding shares of the Company’s Common Stock (which shall be determined
assuming the conversion of all of the shares of Preferred Stock), the Company shall deliver to the Purchaser: 

(i)    within 90 days after the end of each fiscal year of the Company, (A) an audited, consolidated balance sheet
of the Company and its Subsidiaries as of the end of such fiscal year, (B) an audited, consolidated income statement of the Company and its Subsidiaries for such fiscal year and (C) an audited, consolidated statement of cash flows of the
Company and its Subsidiaries for such fiscal year; and 
 (ii)    within 45 days after the end of each of the first
three quarters of each fiscal year of the Company, (A) an unaudited, consolidated balance sheet of the Company and its Subsidiaries as of the end of such fiscal quarter, (B) an unaudited, consolidated income statement of the Company and
its Subsidiaries for such fiscal quarter and (C) an unaudited, consolidated statement of cash flows of the Company and its Subsidiaries for such fiscal quarter. 

  
 -14- 

 (b)    Subject to Section 4.8(c), for so long
as the Purchaser holds record and beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act) of the Preferred Shares, upon the request of Purchaser, the Company shall promptly provide (but
in any case within fifteen (15) calendar days of a request) to Purchaser, the following information: 
 (i)    a
brief statement of the nature of the business of the Company and any subsidiaries and the products and services they offer; and 

(ii)    the most recent consolidated balance sheets and profit and losses and retained earnings statements, and similar
financial statements of the Company for the two (2) most recent fiscal years (such financial information shall be audited, to the extent reasonably available). 

(c)    Notwithstanding the foregoing, financial statements and other reports and information required to be delivered
pursuant to this Section 4.8 filed by the Company with the SEC and available on EDGAR (or such other free, publicly-accessible internet database that may be established and maintained by the SEC as a substitute for or
successor to EDGAR) shall be deemed to have been delivered to the Purchaser on the date on which the Company posts such documents to EDGAR (or such other free, publicly-accessible internet database that may be established and maintained by the SEC
as a substitute for or successor to EDGAR). 
 Section 4.9 Nasdaq Listing. To the extent it has not already done so, promptly
following the execution of this Agreement, the Company shall apply to cause the Closing Shares and the Conversion Shares to be approved for listing on the Nasdaq Stock Market, subject to official notice of issuance. 

Section 4.10 Shareholder Approval. As set forth in the Articles of Amendment, until such time as the Shareholder Approval is
obtained, the Preferred Shares will be subject to limitations on voting rights and will have no voting rights. As promptly as practicable following the Preferred Closing Date (and in any event within sixty (60) Business Days following the
Preferred Closing Date), the Company shall prepare and file with the SEC a proxy statement (the “Proxy Statement”) that includes a proposal for approval by the holders of Common Stock to approve the issuance of Common Stock upon
conversion of the Series B Preferred Stock of the Company issued to Purchaser pursuant to this Agreement as required under the listing rules of the Nasdaq Stock Market (and any successor thereto and any other trading market on which the Common Stock
is listed), including Nasdaq Listing Rule 5635(b) and Nasdaq Listing Rule 5635(d) (the “Shareholder Approval”) at a special meeting of the shareholders of the Company (the “Company Shareholder Meeting”). Subject to
the directors’ fiduciary duties, the Proxy Statement shall include the recommendation from the Board of Directors that the shareholders vote in favor of the Shareholder Approval. The Company shall use reasonable best efforts to solicit from the
shareholders proxies in favor of the Shareholder Approval and to obtain the Shareholder Approval. Purchaser agrees to furnish to the Company all information concerning Purchaser and its Affiliates as the Company may reasonably request in connection
with the preparation and filing of the Proxy Statement and the Company Shareholder Meeting. The Company shall, as promptly as practicable following the earlier of (i) date on which the SEC confirms that it has no further comments on the Proxy
Statement, or (ii) ten calendars days following the filing of a preliminary proxy statement if the Company receives no comments from the SEC during such ten day period, take all action reasonably required, including under the OBCA, the
Company’s Articles of Incorporation and Bylaws and the applicable rules of the Nasdaq Stock Market, to, as soon as reasonably practicable thereafter, duly call, convene and hold the Company Shareholder Meeting. Neither the Closing Shares nor
the Preferred Shares will be entitled to vote in connection with the Shareholder Approval. 

  
 -15- 

 ARTICLE V 

CONDITIONS TO THE PARTIES’ OBLIGATIONS 

Section 5.1 Conditions of the Purchaser. The obligations of the Purchaser to consummate the transactions contemplated hereby to be
consummated at the Preferred Closing are subject to the satisfaction, on or prior to the Preferred Closing Date, (i) on or before October 6, 2020, the condition set forth in Section 5.1(c), and (ii) if the
Preferred Closing has not occurred on or before October 6, 2020, each of the following conditions precedent: 

(a)    Representations and Warranties. Each of the representations and warranties of the Company contained in
(i) Section 2.1(a), Section 2.2(a), Section 2.4 and Section 2.24 of this Agreement shall be true and correct in all material respects on and
as of the Preferred Closing Date with the same effect as though such representations and warranties had been made on and as of the Preferred Closing Date, except for representations and warranties that speak as of a specific date or time other than
the Preferred Closing Date (which need only be true and correct in all material respects as of such date or time), (ii) all other sections of Article II of this Agreement shall be true and correct on and as of the Preferred Closing Date with
the same effect as though such representations and warranties had been made on and as of the Preferred Closing Date, except for representations and warranties that speak as of a specific date or time other than the Preferred Closing Date (which need
only be true and correct in all material respects as of such date or time), except where the failure of such representations and warranties to be so true and correct, without giving effect to any qualification or limitation as to
“materiality,” “Material Adverse Effect” or similar qualifier set forth therein, has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. 

(b)    Covenants. The Company shall have performed and complied in all material respects with all covenants and
agreements required by this Agreement to be performed or complied with by it at or prior to the Preferred Closing. 

(c)    Articles of Amendment. The Articles of Amendment shall have been duly filed with the Secretary of State of
the State of Oregon. 
 Section 5.2 Conditions of the Company. The obligations of the Company to consummate the transactions
contemplated hereby are subject to the satisfaction, on or prior to the Preferred Closing Date, (i) on or before October 6, 2020, the conditions set forth in Section 5.2(c) and
Section 5.2(d), and (ii) if the Preferred Closing has not occurred on or before October 6, 2020, each of the following conditions precedent: 

(a)    Representations and Warranties; Performance. Each of the representations and warranties of the Purchaser
contained in (i) Section 3.1, Section 3.2(a) and Section 3.6 of this Agreement shall be true and correct in all material respects on and as of the Preferred Closing Date with the same
effect as though such representations and warranties had been made on and as of the Preferred Closing Date, except for representations and warranties that speak as of a specific date or time other than the Preferred Closing Date (which need only be
true and correct in all material respects as of such date or time), and (ii) all other sections of Article III of this Agreement shall be true and correct on and as of the Preferred Closing Date with the same effect as though such
representations and warranties had been made on and as of the Preferred Closing Date, except for representations and warranties that speak as of a specific date or time other than the Preferred Closing Date (which need only be true and correct in
all material respects as of such date or time), except where the failure of such representations and warranties to be so true and correct, without giving effect to any qualification or limitation as to “materiality,” “material adverse
effect” or similar qualifier set forth therein, has not had, and would not reasonably be expected to have, individually or in the aggregate, a material adverse effect on the Purchaser’s ability to consummate the transactions under this
Agreement and the Registration Rights Agreement. 

  
 -16- 

 (b)    Covenants. The Purchaser shall have performed and complied
in all material respects with all covenants and agreements required by this Agreement to be performed or complied with by the Purchaser at or prior to the Preferred Closing. 

(c)    Consideration for the Securities. The Purchaser shall have paid the Preferred Shares Purchase Price in full
at the Preferred Closing either by certified check or by wire transfer of immediately available funds to an account designated in writing by the Company. 

(d)    Articles of Amendment. The Articles of Amendment shall have been duly filed with the Secretary of State of
the State of Oregon. 
 Section 5.3 Articles of Amendment. The Company shall use reasonable best efforts to file the Articles of
Amendment, and cause the Articles of Amendment to be declared effective by the Secretary of State of the State of Oregon, as promptly as practicable after the date hereof. 

ARTICLE VI 
 TERMINATION

 Section 6.1 Termination. The obligations of the Company, on the one hand, and the Purchaser, on the other hand, to effect
the Preferred Closing shall terminate as follows: 
 (a)    upon the mutual written consent of the Company and the
Purchaser; 
 (b)    by the Purchaser if any of the applicable conditions set forth in
Section 5.1 shall have become incapable of fulfillment, and shall not have been waived by the Purchaser; 

(c)    by the Company if any of the applicable conditions set forth in Section 5.2 shall have
become incapable of fulfillment, and shall not have been waived by the Company; or 
 (d)    by either the Company or
the Purchaser if the Preferred Closing has not occurred on or prior to November 30, 2020; 
 provided, however, that, except in the case of clause
(d) above, the party seeking to terminate its obligation to effect the Preferred Closing shall not then be in breach of any of its representations, warranties, covenants or agreements contained in this Agreement if such breach has resulted in
the circumstances giving rise to such party’s seeking to terminate its obligation to effect the Preferred Closing. Nothing in this Section 6.1 shall be deemed to release any party from any liability for any breach by
such party of the terms and provisions of this Agreement or to impair the right of any party to compel specific performance by any other party of its obligations under this Agreement. 

ARTICLE VII 

MISCELLANEOUS 

Section 7.1 Survival. Except for (a) the representations and warranties contained in
Section 2.1(a), Section 2.2(a), Section 2.4, Section 2.24, Section 3.1, Section 3.2(a) and
Section 3.6, which shall survive until the expiration of the applicable statute of limitations and (b) in the case of intentional and actual fraud, the representations and warranties set forth herein shall survive for a period
of eighteen (18) months following the Initial Closing Date. All other covenants and agreements of the parties contained herein shall survive the Closing in accordance with their terms. 

  
 -17- 

 Section 7.2 Counterparts. This Agreement may be executed in counterparts, all of
which shall be considered one and the same agreement, and will become effective when such counterpart has been signed by a party and delivered to the other party. Copies of executed counterparts of signature pages to this Agreement may be
transmitted by PDF (portable document format) or facsimile and such PDFs or facsimiles will be deemed as sufficient as if actual signature pages had been delivered. 

Section 7.3 Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the state of New
York, without giving effect to any choice of law or conflict of law rules or provisions (whether of the state of New York or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the state of New York.

 Section 7.4 Binding Arbitration. 

(a)    The parties hereto desire and agree that any arbitration proceedings shall be conducted before one arbitrator to be
selected pursuant to the Comprehensive Arbitration Rules (the “Arbitrator”) as expeditiously as possible and acknowledge that expeditious arbitration is in the interest of the parties hereto. The parties hereto agree that the arbitration
must be concluded, including the rendering of any award by the Arbitrator (the “Award”), not more than ninety (90) days following selection of the Arbitrator. The parties hereto further agree that the Arbitrator shall have the
authority to impose any interim deadlines, including shortening any deadlines provided in the Comprehensive Arbitration Rules, to ensure that this ninety (90)-day deadline is met. The Arbitrator must agree to
the foregoing ninety (90) day deadline before accepting appointment. Failure to meet the ninety (90) day deadline, however, will not render the Award invalid, unenforceable or subject to being vacated. However, the parties hereto may
mutually agree to modify the ninety (90)-day deadline and, if they do so, the Arbitrator shall accommodate such parties’ mutual agreement. The Arbitrator shall have no power to alter or disregard any
express language in this Agreement and may not reform this Agreement under equitable or other principles. 
 (b)    The
parties hereto shall maintain the confidential nature of the arbitration proceeding, except as may be necessary in connection with a court application for a provisional or preliminary remedy, a court action to challenge or enforce the Award, or as
otherwise required by law or judicial decision. The parties hereto further agree that the Arbitrator shall render the Award in writing and explain the decision which, to the extent possible, shall not include confidential information. 

(c)    The parties hereto waive to the fullest extent permitted by law any rights to appeal or to review of the Award by
any court or tribunal. 
 (d)    For the avoidance of doubt, in the event of a conflict between this
Section 7.4 and the Comprehensive Arbitration Rules, this Section 7.4 controls. 

Section 7.5 Entire Agreement; No Third Party Beneficiary. This Agreement and the Registration Rights Agreement contain the entire
agreement by and among the parties with respect to the subject matter hereof and all prior negotiations, writings and understandings relating to the subject matter of this Agreement. This Agreement is not intended to confer upon any Person not a
party hereto (or their successors and permitted assigns) any rights or remedies hereunder. 
 Section 7.6 Expenses. All fees,
costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby, including accounting and legal fees shall be paid by the party incurring such expenses, except that, upon consummation of the Closing, the
Company shall reimburse the Purchaser for all reasonable and documented out-of-pocket costs and expenses, including legal fees, in an aggregate amount not to exceed two
hundred fifty thousand dollars ($250,000), incurred by the Purchaser in connection with the transaction contemplated by this Agreement. 

  
 -18- 

 Section 7.7 Notices. All notices, requests, demands and other communications
under this Agreement shall be in writing and shall be deemed to have been duly given or made as follows: (a) if sent by registered or certified mail in the United States return receipt requested, upon receipt; (b) if sent by nationally
recognized overnight air courier, one (1) Business Day after mailing; (c) if sent by e-mail transmission, upon receipt; and (d) if otherwise actually personally delivered, when delivered,
provided, that such notices, requests, demands and other communications are delivered to the address set forth below, or to such other address as any party shall provide by like notice to the other parties to this Agreement: 

If to the Company, to: 

Digimarc Corporation 
 9405 SW
Gemini Drive 
 Beaverton, OR 97008 

Attention: Robert Chamness 

Email: Robert.Chamness@digimarc.com 

with a copy (which shall not constitute notice) to: 

Perkins Coie LLP 
 1120 NW
Couch Street, 10th Floor 
 Portland, OR 97209-4128 

Attention: Roy W. Tucker; Gina Eiben 

Email: rtucker@perkinscoie.com; geiben@perkinscoie.com 

If to a Purchaser, to: 
 TCM
Strategic Partners L.P. 
 26 Tahiti Beach Island Road 

Coral Gables, FL 33143 

Attention: Riley McCormack 
 E-mail: rm@tracercap.com 
 with a copy (which shall not constitute notice) to: 

Sidley Austin LLP 
 555
California Street, Suite 2000 
 San Francisco, California 94104 

Attention: Vijay S. Sekhon and Benson Cohen 

E-mail: vsekhon@sidley.com and brcohen@sidley.com 

Section 7.8 Successors and Assigns. This Agreement will be binding upon and inure to the benefit of the parties hereto and their
respective successors and permitted assigns. This Agreement may be assigned in connection with a Transfer to a Permitted Transferee permitted by Section 4.2(a)(i). No other assignment of this Agreement or of any rights or obligations hereunder
may be made by any party hereto without the prior written consent of the other party. Any purported assignment or delegation in violation of this Agreement shall be null and void ab initio. 

Section 7.9 Headings. The Section, Article and other headings contained in this Agreement are inserted for convenience of
reference only and will not affect the meaning or interpretation of this Agreement. 

  
 -19- 

 Section 7.10 Amendments and Waivers. This Agreement may not be modified or
amended except by an instrument or instruments in writing signed by the parties hereto. Either party may, only by an instrument in writing, waive compliance by the other party with any term or provision hereof on the part of such other party or
parties hereto to be performed or complied with. No failure or delay of a party in exercising any right or remedy hereunder shall operate as a waiver thereof, nor will any single or partial exercise of any right or power, or any abandonment or
discontinuance of steps to enforce such right or power, preclude any other or further exercise thereof or the exercise of any other right or power. The waiver by a party of a breach of any term or provision hereof shall not be construed as a waiver
of any subsequent breach. The rights and remedies of the parties hereunder are cumulative and are not exclusive of any rights or remedies that they would otherwise have hereunder. 

Section 7.11 Interpretation; Absence of Presumption. 

(a)    For the purposes hereof: (i) words in the singular shall be held to include the plural and vice versa and
words of one gender shall be held to include the other gender as the context requires; (ii) the terms “hereof,” “herein,” and “herewith” and words of similar import shall, unless otherwise stated, be construed to
refer to this Agreement as a whole (including all of the Schedules and Exhibits) and not to any particular provision of this Agreement, and Article, Section, paragraph, Exhibit and Schedule references are to the Articles, Sections, paragraphs,
Exhibits, and Schedules to this Agreement unless otherwise specified; (iii) the word “including” and words of similar import when used in this Agreement shall mean “including, without limitation,” unless the context
otherwise requires or unless otherwise specified; and (iv) the word “or” shall not be exclusive. 

(b)    With regard to each and every term and condition of this Agreement and any and all agreements and instruments
subject to the terms hereof, the parties hereto understand and agree that the same have or has been mutually negotiated, prepared and drafted, and if at any time the parties hereto desire or are required to interpret or construe any such term or
condition or any agreement or instrument subject hereto, no consideration will be given to the issue of which party hereto actually prepared, drafted or requested any term or condition of this Agreement or any agreement or instrument subject hereto.

 Section 7.12 Severability. Any provision hereof that is held to be invalid, illegal or unenforceable in any respect by a
court of competent jurisdiction, shall be ineffective only to the extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining provisions hereof, provided, however, that the parties will attempt
in good faith to reform this Agreement in a manner consistent with the intent of any such ineffective provision for the purpose of carrying out such intent. 

Section 7.13 Specific Performance. The parties hereto agree that irreparable damage could occur and that a party may not have any
adequate remedy at law in the event that any of the provisions of this Agreement are not performed in accordance with their terms or were otherwise breached. Accordingly, each party shall without the necessity of proving the inadequacy of money
damages or posting a bond be entitled to seek an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms, provisions and covenants contained therein, this being in addition to any other remedy to which
they are entitled at law or in equity. 
 Section 7.14 Public Announcement. Subject to each party’s disclosure obligations
imposed by applicable law or the rules of any stock exchange upon which its securities are listed, each of the parties hereto will cooperate with the other in the development and distribution of all news releases and other public information
disclosures with respect to this Agreement and any of the transactions contemplated by this Agreement, and neither the Company nor Purchaser will make any such news release or public disclosure without first consulting with the other, and, in each
case, also receiving the other’s consent (which shall not be unreasonably withheld or delayed) and each party shall coordinate with the party 

  
 -20- 

 
whose consent is required with respect to any such news release or public disclosure. Notwithstanding the foregoing, this Section 7.14 shall not apply to any press
release or other public statement made by the Company or Purchaser (a) that is consistent with prior disclosure and does not contain any information relating to the transactions that has not been previously announced or made public in
accordance with the terms of this Agreement or (b) is made to its auditors, attorneys, accountants, financial advisors, limited partners or other Permitted Transferees. 

(The next page is the signature page) 

  
 -21- 

 The parties have caused this Subscription Agreement to be executed as of the date first
written above. 
  

			
	DIGIMARC CORPORATION
		
	By:	 	 /s/ Robert P. Chamness

		 	 Name: Robert P. Chamness
 Title: Executive
Vice President, Chief Legal
           Officer and Secretary

	
	 TCM STRATEGIC PARTNERS L.P.
  

	By: TCM Strategic GP LLC, its general partner
		
	By:	 	 /s/ Riley McCormack

		 	 Name: Riley McCormack
 Title:
Manager

  
 -22- 

 EXHIBIT A 

DEFINED TERMS 
 1. The
following capitalized terms have the meanings indicated: 
 “Affiliate” of any Person means any Person, directly or
indirectly, Controlling, Controlled by or under common Control with such Person. 
 “Articles of Incorporation” means the
Company’s Articles of Incorporation, as the same may be further amended, supplemented or restated. 
 “Board of
Directors” means the Company’s board of directors. 
 “Business Day” means any day other than a Saturday, a
Sunday or any day on which the Federal Reserve Bank of New York is authorized or required by law or executive order to close or be closed. 

“Bylaws” means the Bylaws of the Company, adopted on April 29, 2010, as the same may be further amended, supplemented or
restated. 
 “Code” means the Internal Revenue Code of 1986, as amended. 

“Closing Shares Purchase Price” has the meaning set forth in Section 1.1. 

“Closings” has the meaning set forth in Section 1.2. 

“Control” (including its correlative meanings “under common Control with” and “Controlled by”) means,
with respect to any Person, the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through ownership of securities or partnership or other interests, by contract or
otherwise. 
 “Designated Account” has the meaning set forth in Section 1.2. 

“Environmental Permit” means any permit, license, approval or other authorization under any applicable law, rule or
regulations of the United States or of any state, municipality or other subdivision thereof relating to pollution or protection of health or the environment, including laws, regulations or other requirements relating to emissions, discharges,
releases or threatened releases of pollutants, contaminants or Hazardous Substances or toxic materials or wastes into ambient air, surface water, ground water or land, or otherwise relating to the manufacture, processing, distribution, recycling,
presence, use, treatment, storage, disposal, transport, or handling of, wastes, pollutants, contaminants or Hazardous Substances. 

“ERISA” means the Employee Retirement Income Security Act of 1974, as amended. 

“ERISA Documents” means all material “employment benefit plans” as defined in Section 3(3) of ERISA
that are maintained or sponsored by the Company or its Subsidiaries for the benefit of their respective current or former employees and with respect to which the Company or its Subsidiaries have any liability. 

“ERISA Regulations” means the regulations promulgated by the Department of Labor in 29 C.F.R. § 2510.3-101, and any amendments or successor regulations thereto, as modified by Section 3(42) of ERISA. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended. 

  
 A-1 

 “GAAP” means generally accepted accounting principles as in effect in the
United States. 
 “Governmental Entity” means any supranational, national, state, municipal, local or foreign government,
any court, tribunal, arbitrator, administrative agency, commission or other governmental official, authority or instrumentality. 

“Government Official” means any officer or employee of a foreign governmental authority or any department, agency, or
instrumentality thereof, or of a public international organization, or any person acting in an official capacity for or on behalf of any such foreign governmental authority or department, agency, or instrumentality, or for or on behalf of any such
public international organization, or any political party, party official, or candidate thereof, excluding officials of the governments of the United States, the several states thereof, any local subdivision of any of them or any agency, department
or unit of any of the foregoing. 
 “Hazardous Substance” means any waste, substance, product or material defined or
regulated as “hazardous” or “toxic” by any applicable law, rule, regulation or order described in the definition of “Requirements of Environmental Law,” including petroleum and any fraction thereof, and
any radioactive materials and waste. 
 “Hedging Transactions” means the entering (a) into a Short Sale, (b) into
or establishment of any agreement constituting a “put equivalent position,” as defined by Rule 16a-1(h) of the Exchange Act, or (c) otherwise entering into a hedging transaction the
primary purpose of which is to offset the loss which results from a decline in the market price of the Common Stock. 
 “Investment
Company Act” mean the Investment Company Act of 1940, as amended. 
 “Material Adverse Effect” means any event,
circumstance, change or occurrence that has had or would reasonably be expected to have a material adverse effect upon (a) the financial condition, assets, liabilities, operations or results of operations of the Company and its Subsidiaries,
taken as a whole or (b) the ability of the Company to consummate the transactions contemplated by this Agreement in a timely manner; provided, however, that any such effect resulting or arising from or relating to any of the
following matters shall not be considered when determining whether a Material Adverse Effect has occurred or would reasonably be expected to occur: (a) any change, development, occurrence or event affecting the industry in which the Company and
its Subsidiaries operate; (b) any conditions affecting the United States general economy or the general economy in any geographic area in which the Company or its Subsidiaries operate or developments or changes therein or the financial and
securities markets and credit markets in the United States or elsewhere in the world; (c) political conditions, including the continuation, occurrence, escalation, outbreak or worsening of any hostilities, war, political action, acts of
terrorism, sabotage or military conflicts, whether or not pursuant to the declaration of an emergency or war; (d) any conditions resulting from the existence, occurrence or continuation of any force majeure events, including any earthquakes,
floods, hurricanes, tropical storms, fires or other natural or manmade disasters, any epidemic, pandemic (including COVID-19) or other similar outbreak (including any
non-human epidemic, pandemic or other similar outbreak) or any other national, international or regional calamity; (e) changes in any law, rule, regulation or GAAP; (f) any action taken or omitted to
be taken by or at the written request or with the written consent of Purchaser; (g) any announcement of this Agreement or the transactions contemplated hereby; (h) changes in the market price or trading volume of Common Stock or any other
equity, equity-related or debt securities of the Company or its Affiliates (it being understood that the underlying circumstances, events or reasons giving rise to any such change can be taken into account in determining whether a Material Adverse
Effect has occurred or would reasonably be expected to occur); or (i) any failure to meet any internal or public projections, forecasts, estimates or guidance for any period (it being understood that the underlying circumstances, events or
reasons giving rise to any such failure can be taken into account in determining whether a Material Adverse Effect has 

  
 A-2 

 
occurred or would reasonably be expected to occur); provided, that any of the matters described in clauses (a), (b) or (c), will be taken into account for purposes of determining whether
or not a Material Adverse Effect has occurred to the extent that such matter disproportionately and adversely affects the Company and its Subsidiaries, taken as a whole, as compared with other companies operating in the industry in which the Company
and its Subsidiaries operate. 
 “OBCA” means the Oregon Business Corporation Act of the State of Oregon (as amended from
time to time). 
 “Permitted Transferee” means any investment fund, investment vehicle or account Controlled by the
Principal. 
 “Person” means an individual, corporation, partnership, limited liability company, joint venture, trust or
unincorporated organization or a government or agency or political subdivision thereof. 
 “Preferred Shares Purchase
Price” has the meaning set forth in Section 1.1. 
 “Principal” means Riley McCormack.

 “Registration Rights Agreement” means the Registration Rights Agreement between the Company and the Purchaser in the
form attached to the Agreement as Exhibit C. 
 “Representatives” means a Persons’ Affiliates, employees,
agents, consultants, accountants, attorneys or financial advisors and direct or indirect members or partners or Affiliates of the foregoing. 

“Requirements of Environmental Law” means all requirements imposed by any law (including the Resource Conservation and
Recovery Act, the Comprehensive Environmental Response, Compensation, and Liability Act, the Clean Water Act, the Clean Air Act, and any state analogues of any of the foregoing), rule, regulation, or order of any governmental authority which relate
to (a) pollution, protection or clean-up of the air, surface water, ground water or land; (b) solid, gaseous or liquid waste or Hazardous Substance generation, recycling, reclamation, release,
threatened release, treatment, storage, disposal or transportation; (c) exposure of Persons or property to Hazardous Substances; or (d) the manufacture, presence, processing, distribution in commerce, use, discharge, releases, threatened
releases, emissions or storage of Hazardous Substances into the environment. 
 “Restricted Securities” means Purchased
Shares or Conversion Shares required to bear the legend set forth in Section 4.3(a) under the applicable provisions of the Securities Act. 

“SEC” means the Securities and Exchange Commission. 

“SEC Documents” means all reports, schedules, registration statements, proxy statements and other documents (including all
amendments, exhibits and schedules thereto) filed by the Company with the SEC on or after January 1, 2019. 
 “Securities
Act” means the Securities Act of 1933, as amended. 
 “Short Sale” means a sale of Common Stock that is marked as
a short sale. 
 “Subsidiary” means, when used with reference to a party, any corporation or other organization, whether
incorporated or unincorporated, of which such party or any other Subsidiary of such party is a general partner or serves in a similar capacity, or, with respect to such corporation or other organization, at least a majority of the securities or
other interests having by their terms ordinary voting power to elect a majority of the board of directors or others performing similar functions is directly or indirectly owned or controlled by such party or by any one or more of its Subsidiaries,
or by such party and one or more of its Subsidiaries. 

  
 A-3 

 “Tax” and “Taxes” means all federal, state, local and
foreign taxes (including, without limitation, income, franchise, property, sales, withholding, payroll and employment taxes), assessments, fees or other charges imposed by any Governmental Entity, including any interest, additions to tax or
penalties applicable thereto. 
 “Tax Return” means any return, report or similar filing (including the attached schedules)
filed or required to be filed with respect to Taxes (and any amendments thereto), including any information return, claim for refund or declaration of estimated Taxes. 

“Transfer” means, with respect to any security, any direct or indirect (a) sale, transfer, conveyance or encumbrance of
such security, or the grant of any option or other right to an interest therein, whether voluntary, involuntary or by operation of law; provided that such transaction with respect to any security or ownership of Purchaser shall not constitute a
Transfer so long as Principal continues to Control Purchaser following such transaction, or (b) entry into any hedge, swap or other agreement or transaction that transfers, in whole or in part, directly or indirectly, the economic consequence
of ownership of Common Stock. The term “Transferred” shall have a correlative meaning. 
 “Treasury
Regulations” means the U.S. Treasury regulations promulgated under the Code, as amended. 
 2. The following terms are defined in
the Sections of the Agreement indicated: 
 INDEX OF TERMS 
  

			
	 Term
	 	 Section

	Agreement	 	Preamble
	Closing	 	1.2
	Closing Date	 	1.2
	Closing Shares	 	Preamble
	Common Stock	 	2.4(a)
	Company	 	Preamble
	Company Shareholder Meeting	 	4.10
	Conversion Shares	 	2.4(c)
	Disclosure Schedule	 	Article II
	Financial Statements	 	2.7
	Preferred Shares	 	Preamble
	Preferred Stock	 	2.4(a)
	Proxy Statement	 	4.10
	Purchased Shares	 	Preamble
	Purchaser	 	Preamble
	Purchaser Designee	 	4.1(b)
	SECURITIES ACT	 	4.3(a)
	Series B Preferred Stock	 	Preamble
	Shareholder Approval	 	4.10
	Shares	 	2.4(c)
	USRPHC	 	2.12

  
 A-4EX-10.2

 Exhibit 10.2 

REGISTRATION RIGHTS AGREEMENT 

This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is entered into as of September 29, 2020, by and between
Digimarc Corporation, an Oregon corporation (including its successors and permitted assigns, the “Company”), and TCM Strategic Partners L.P., a Delaware limited partnership (including its successors and permitted assigns, the
“Investor”). Capitalized terms used but not defined elsewhere herein are defined in Exhibit A. 
 The Company has
entered into a Subscription Agreement, dated as of the date hereof (as amended from time to time, the “Subscription Agreement”), with the Investor, pursuant to which the Company is selling to the Investor, and the Investor is
purchasing from the Company, (i) 2,542,079 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and (ii) 16,970 shares of the Company’s Series B Convertible Preferred Stock (the
“Series B Preferred Stock”), which is convertible into shares of Common Stock. 
 As a condition to each of the
parties’ obligations under the Subscription Agreement, the Company and the Investor are entering into this Agreement for the purpose of granting certain registration and other rights to the Investor. 

In consideration of the premises and the mutual representations, warranties, covenants and agreements contained herein, and for other good and
valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree as follows: 
 ARTICLE I

 RESALE SHELF REGISTRATION 

Section 1.1 Resale Shelf Registration Statement. Subject to the other applicable provisions of this Agreement, the Company shall
file on or before the nine (9) month anniversary of the date hereof a registration statement covering the sale or distribution from time to time by the Holders, on a delayed or continuous basis pursuant to Rule 415 of the Securities Act, of all
of the Registrable Securities on Form S-3 (except if the Company is not then eligible to register for resale the Registrable Securities on Form S-3, then such
registration shall be on Form S-1 or another appropriate form and shall provide for the registration of such Registrable Securities for resale by such Holders in accordance with any reasonable method of
distribution elected by the Holders) (the “Resale Shelf Registration Statement” and such registration, the “Resale Shelf Registration”). The Company shall use its reasonable best efforts to cause such Resale Shelf
Registration Statement to be declared effective by the Commission as promptly as practicable after the filing thereof, but in any event prior to the date that is the one (1) year anniversary of the date of this Agreement. 

Section 1.2 Effectiveness Period. Once declared effective, the Company shall, subject to Section 3.1(n)
of this Agreement, cause the Resale Shelf Registration Statement to be continuously effective and usable until such time as there are no longer any Registrable Securities (the “Effectiveness Period”). 

Section 1.3 Subsequent Shelf Registration. If any Shelf Registration ceases to be effective under the Securities Act for any
reason at any time during the Effectiveness Period, the Company shall use its reasonable best efforts to promptly cause such Shelf Registration to again become effective under the Securities Act (including obtaining the prompt withdrawal of any
order suspending the effectiveness of such Shelf Registration), and in any event shall within thirty (30) days of such cessation of effectiveness, amend such Shelf Registration in a manner reasonably expected to obtain the withdrawal of any
order suspending the effectiveness of such Shelf Registration or, file an additional registration statement (a 

 
“Subsequent Shelf Registration”) for an offering to be made on a delayed or continuous basis pursuant to Rule 415 of the Securities Act registering the resale from time to time
by the Holders thereof of all securities that are Registrable Securities as of the time of such filing. If a Subsequent Shelf Registration is filed, the Company shall use its reasonable best efforts to (a) cause such Subsequent Shelf
Registration to become effective under the Securities Act as promptly as is reasonably practicable after such filing, but in no event later than the date that is ninety (90) days after such Subsequent Shelf Registration is filed and
(b) keep such Subsequent Shelf Registration (or another Subsequent Shelf Registration) continuously effective until the end of the Effectiveness Period. Any such Subsequent Shelf Registration shall be a Registration Statement on Form S-3 to the extent that the Company is eligible to use such form, and if the Company is a WKSI as of the filing date, such Registration Statement shall be an Automatic Shelf Registration Statement. Otherwise, such
Subsequent Shelf Registration shall be on Form S-1 or another appropriate form and shall provide for the registration of such Registrable Securities for resale by such Holders in accordance with any reasonable
method of distribution elected by the Holders. 
 Section 1.4 Supplements and Amendments. The Company shall supplement and amend
any Shelf Registration if required by the rules, regulations or instructions applicable to the registration form used by the Company for such Shelf Registration if required by the Securities Act or as reasonably requested by the Holders covered by
such Shelf Registration. 
 Section 1.5 Subsequent Holder Notice. If a Person becomes a Holder of Registrable Securities after a
Shelf Registration becomes effective under the Securities Act, then the Company shall, as promptly as is reasonably practicable following delivery of written notice to the Company of such Person becoming a Holder and requesting for its name to be
included as a selling securityholder in the prospectus related to the Shelf Registration (a “Subsequent Holder Notice”): 

(a)    if required and permitted by applicable law, file with the Commission a supplement to the related prospectus or a
post-effective amendment to the Shelf Registration so that such Holder is named as a selling securityholder in the Shelf Registration and the related prospectus in such a manner as to permit such Holder to deliver a prospectus to purchasers of the
Registrable Securities in accordance with applicable law; 
 (b)    if, pursuant to
Section 1.5(a), the Company shall have filed a post-effective amendment to the Shelf Registration that is not automatically effective, use its reasonable best efforts to cause such post-effective amendment to become
effective under the Securities Act as promptly as is reasonably practicable, but in any event by the date that is ninety (90) days after the date such post-effective amendment is required by Section 1.5(a) to be filed;
and 
 (c)    notify such Holder as promptly as is reasonably practicable after the effectiveness under the Securities
Act of any post-effective amendment filed pursuant to Section 1.5(a). 
 Section 1.6 Take-Down. 

(a)    Notice. Subject to the other applicable provisions of this Agreement, at any time that any Shelf
Registration Statement is effective, if a Holder delivers a notice to the Company (a “Take-Down Notice”) stating that it intends to effect a sale or distribution of all or part of its Registrable Securities included by it on any
Shelf Registration Statement (a “Shelf Offering”) and stating the number of Registrable Securities to be included in such Shelf Offering, then, subject to the other applicable provisions of this Agreement, the Company shall amend or
supplement the Shelf Registration Statement as may be necessary in order to enable such Registrable Securities to be sold and distributed pursuant to the Shelf Offering. 

  
 2 

 (b)    Underwritten Offering. The Holders of Registrable
Securities may on no more than four (4) occasions after the Resale Shelf Registration Statement becomes effective deliver a written notice to the Company specifying that the sale of some or all of the Registrable Securities subject to the Shelf
Registration is intended to be conducted through an underwritten offering (the “Underwritten Offering”); provided, however, that the anticipated gross proceeds of any such Underwritten Offering must not be less than
twenty-five million dollars ($25,000,000) (unless the Holders are proposing to sell all of their remaining Registrable Securities). In the event of an Underwritten Offering: 

(c)    The Holders of a majority of the Registrable Securities participating in the Underwritten Offering shall select the
managing underwriter or underwriters to administer the Underwritten Offering; provided, that the choice of such managing underwriter or underwriters shall be subject to the consent of the Company, which is not to be unreasonably withheld,
conditioned or delayed. 
 (d)    Notwithstanding any other provision of this Section 1.6, if
the managing underwriter or underwriters of a proposed Underwritten Offering advises the Board of Directors of the Company that in its or their opinion the number of Registrable Securities requested to be included in such Underwritten Offering
exceeds the number which can be sold in such Underwritten Offering in light of market conditions, the Registrable Securities shall be included on a pro rata basis upon the number of securities that each Holder shall have requested to be included in
such offering. If any Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw therefrom by written notice to the Company and the managing underwriter or underwriters. No Holder shall be named as an
“underwriter” in any Registration Statement without such Holder’s prior written consent. 
 ARTICLE II 

COMPANY REGISTRATION 

Section 2.1 Piggyback Registration. If at any time or from time to time the Company determines to file a registration statement
with respect to an offering (or to make an underwritten public offering pursuant to a previously filed registration statement) of its Common Stock, whether or not for its own account (other than an Excluded Registration), the Company will, at each
such time: 
 (a)    promptly give to each Holder written notice thereof, which notice shall be given, to the extent
reasonably practicable, no later than ten (10) business days prior to the filing or launch date (except in the case of an offering that is an “overnight offering”, in which case such notice must given no later than one
(1) business day prior to the filing or launch date); and 
 (b)    subject to
Section 2.2, include in such registration or underwritten offering (and any related qualification under blue sky laws or other compliance) all the Registrable Securities specified in a written request or requests made
within ten (10) days after receipt of such written notice from the Company by any Holder, if the Registrable Securities requested by such Holder for inclusion in such registration or underwritten offering have a market value of $1,000,000 or
more immediately prior to the Company’s receipt of such request. 
 Section 2.2 Underwriting. The right of any Holder to
registration pursuant to this Article II shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of Registrable Securities in the underwriting to the extent provided herein. Each Holder proposing to
distribute its securities through such underwriting shall (together with the Company and the other holders distributing their securities through such underwriting) enter into and perform such Holder’s obligations under an underwriting agreement
with the managing underwriter selected for such underwriting by the Company (such underwriting agreement to be in the form negotiated by the Company). Notwithstanding any other provision of this Article II, if the managing underwriter or
underwriters of a proposed underwritten offering 

  
 3 

 
with respect to which Holders of Registrable Securities have exercised their piggyback registration rights advise the Board of Directors of the Company that in its or their opinion the number of
Registrable Securities requested to be included in the offering thereby and all other securities proposed to be sold in the offering exceeds the number which can be sold in such underwritten offering without being likely to have an adverse effect on
the price, timing or distribution of the Registrable Securities offered in light of market conditions, the Registrable Securities and such other securities to be included in such underwritten offering shall be allocated, (a) first, up to the
total number of securities that the Company has requested to be included in such registration and (b) second, and only if all the securities referred to in clause (a) have been included, up to the total number of securities that the
Holders and other holders of securities that have contractual rights to be included in such registration have requested to be included in such offering (pro rata based upon the number of securities that each of them shall have requested to be
included in such offering) and (c) third, and only if all the securities referred to in clause (b) have been included, all other securities proposed to be included in such offering that, in the opinion of the managing underwriter or
underwriters can be sold without having such adverse effect. If any Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw therefrom by written notice to the Company and the managing underwriter or underwriters.
Any securities excluded or withdrawn from such underwriting shall be withdrawn from such registration. 
 Section 2.3 Right to
Terminate Registration. The Company shall have the right to terminate or withdraw any registration under this Article II prior to the effectiveness thereof, whether or not any Holder has elected to include securities in such registration.

 ARTICLE III 

ADDITIONAL PROVISIONS REGARDING REGISTRATION RIGHTS 

Section 3.1 Registration Procedures. In the case of each registration effected by the Company pursuant to Article I or
II, the Company will keep each Holder participating in such Registration reasonably informed as to the status thereof and, at its expense, the Company will: 

(a)    prepare and file with the Commission a registration statement with respect to such securities in accordance with
the applicable provisions of this Agreement; 
 (b)    prepare and file with the Commission such amendments, including
post-effective amendments, and supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition
of all securities covered by such registration statement (including to permit the intended method of distribution thereof) and as may be necessary to keep the registration statement continuously effective for the period set forth in this Agreement;

 (c)    furnish to the Holders participating in such registration and to their legal counsel copies of the
registration statement proposed to be filed, and provide such Holders and their legal counsel the reasonable opportunity to review and comment on such registration statement; 

(d)    furnish to the Holders participating in such registration and to the underwriters of the securities being
registered such reasonable number of copies of the registration statement, preliminary prospectus and final prospectus as the such underwriters may reasonably request in order to facilitate the public offering of such securities; 

(e)    use reasonable best efforts to notify each Holder of Registrable Securities covered by such registration statement
at any time when a prospectus relating thereto is required to be delivered under the Securities Act of the Company’s knowledge of the happening of any event as a result of which the prospectus included in such registration statement, as then in
effect, includes an untrue statement of a 

  
 4 

 
material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading or incomplete in the light of the circumstances then
existing, and, subject to Section 3.1(n), at the request of any such Holder, prepare promptly and furnish to such Holder a reasonable number of copies of a supplement to or an amendment of such prospectus as may be
necessary so that, as thereafter delivered to the purchaser of such shares, such prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein not misleading or incomplete in the light of the circumstances then existing; 
 (f)    use reasonable best
efforts to register and qualify the securities covered by such registration statement under such other securities or blue sky laws of such jurisdictions as shall be reasonably requested by the Holders; provided, however, that the
Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of process in any such states or jurisdictions; 

(g)    in the event that the Registrable Securities are being offered in an underwritten public offering, enter into and
perform its obligations under an underwriting agreement on customary terms and in accordance with the applicable provisions of this Agreement; 

(h)    in connection with an underwritten public offering, cause its officers to use their reasonable best efforts to
support the marketing of the Registrable Securities covered by such offering (including participation in “road shows” or other similar marketing efforts); 

(i)    if such securities are being sold through underwriters, (i) furnish, on the date that such Registrable
Securities are delivered to the underwriters, an opinion, dated as of such date, of the legal counsel representing the Company for the purposes of such registration, in form and substance as is customarily given to underwriters in an underwritten
public offering, addressed to the underwriters, if any, and a “negative assurance letter,” dated as of such date, of the legal counsel representing the Company for purposes of such registration, in form and substance as is customarily
given to underwriters and (ii) furnish, on the date of the underwriting agreement and on the date that the Registrable Securities are delivered to the underwriters, a letter dated as of such date, from the independent certified public
accountants of the Company, in form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the underwriters; and 

(j)    use reasonable best efforts to list the Registrable Securities covered by such registration statement with any
securities exchange on which the Common Stock is then listed; 
 (k)    in connection with a customary due diligence
review, make available for inspection by the Holders, any underwriter participating in any such disposition of Registrable Securities, if any, and any counsel or accountants retained by the Holders or underwriter (collectively, the “Offering
Persons”), pertinent financial and other records, corporate documents and properties of the Company and its subsidiaries, and cause the officers, directors and employees of the Company and its subsidiaries to supply such information and
participate in customary due diligence sessions in each case reasonably requested by any such representative, underwriter, counsel or accountant in connection with such registration statement, subject to customary confidentiality obligations to be
agreed with the Offering Persons; 
 (l)    cooperate with the Holders and each underwriter or agent participating in
the disposition of Registrable Securities and their respective counsel in connection with any filings required to be made with FINRA; 

  
 5 

 (m)    as promptly as is reasonably practicable notify the Holders
(i) when the prospectus or any prospectus supplement or post-effective amendment has been filed and, with respect to such registration statement or any post-effective amendment, when the same has become effective, (ii) of any request by
the Commission or other federal or state governmental authority for amendments or supplements to such registration statement or related prospectus or to amend or to supplement such prospectus or for additional information, (iii) of the issuance
by the Commission of any stop order suspending the effectiveness of such registration statement or the initiation of any proceedings for such purpose, (iv) if at any time the Company has reason to believe that the representations and warranties
of the Company or any of its subsidiaries contained in any agreement (including any underwriting agreement contemplated by Section 3.1(g) above) cease to be true and correct or (v) of the receipt by the Company of any
notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any proceeding for such purpose; and 

(n)    notwithstanding any other provision of this Agreement, if the Board of Directors of the Company has determined in
good faith that the disclosure necessary for continued use of the prospectus and registration statement by the Holders could be materially detrimental to the Company, the Company shall have the right not to file or not to cause the effectiveness of
any registration covering any Registrable Securities and to suspend the use of the prospectus and the registration statement covering any Registrable Security for such period of time as its use would be materially detrimental to the Company by
delivering written notice of such suspension to all Holders listed on the Company’s records; provided, however, that in any 12-month period the Company may exercise the right to such suspension not more
than twice. From and after the date of a notice of suspension under this Section 3.1(n), each Holder agrees not to use the prospectus or registration statement until the earlier of (i) notice from the Company that such
suspension has been lifted or (ii) the day following the ninetieth (90th) day of suspension within any 12-month period. 

Section 3.2 Limitation on Subsequent Registration Rights. From and after the date hereof, the Company shall not enter into any
agreement granting any holder or prospective holder of any securities of the Company registration rights with respect to such securities that conflict with the rights granted to the Holders herein, without the prior written consent of Holders of a
majority of the Registrable Securities. It is agreed that the granting of pro rata registration rights to any other investor in the Company shall not be considered to conflict with the rights granted to the Holders herein. 

Section 3.3 Expenses of Registration. All Registration Expenses incurred in connection with any registration pursuant to
Article I or II shall be borne by the Company. All Selling Expenses relating to securities registered on behalf of the Holders shall be borne by the Holders of the registered securities included in such registration. 

Section 3.4 Information by Holders. The Holder or Holders of Registrable Securities included in any registration shall furnish to
the Company such information regarding such Holder or Holders and their Affiliates, the Registrable Securities held by them and the distribution proposed by such Holder or Holders and their Affiliates as the Company may reasonably request in writing
and as shall be required in connection with any registration, qualification or compliance referred to in this Agreement. It is understood and agreed that the obligations of the Company under Article I or II are conditioned on the
timely provisions of the foregoing information by such Holder or Holders and, without limitation of the foregoing, will be conditioned on compliance by such Holder or Holders with the following: 

(a)    such Holder or Holders will, and will cause their respective Affiliates to, cooperate with the Company in
connection with the preparation of the applicable registration statement, and for so long as the Company is obligated to keep such registration statement effective, such Holder or Holders will and will cause their respective Affiliates to, provide
to the Company, in writing and in a timely manner, for use in such registration statement (and expressly identified in writing as such), all information regarding themselves and their respective Affiliates and such other information as may be
required by applicable law 

  
 6 

 
to enable the Company to prepare such registration statement and the related prospectus covering the applicable Registrable Securities owned by such Holder or Holders and to maintain the currency
and effectiveness thereof; 
 (b)    during such time as such Holder or Holders and their respective Affiliates may be
engaged in a distribution of the Registrable Securities, such Holder or Holders will, and they will cause their Affiliates to, comply with all laws applicable to such distribution, including Regulation M promulgated under the Exchange Act, and, to
the extent required by such laws, will, and will cause their Affiliates to, among other things: (i) not engage in any stabilization activity in connection with the securities of the Company in contravention of such laws; (ii) distribute
the Registrable Securities acquired by it solely in the manner described in the applicable registration statement; and (iii) if required by applicable law, cause to be furnished to each agent or broker-dealer to or through whom such Registrable
Securities may be offered, or to the offeree if an offer is made directly by such Holder or Holders or their respective Affiliates, such copies of the applicable prospectus (as amended and supplemented to such date) and documents incorporated by
reference therein as may be required by such agent, broker-dealer or offeree; 
 (c)    such Holder or Holders shall,
and they shall cause their respective Affiliates to, permit the Company and its representatives and agents to examine such documents and records and will supply in a timely manner any information as they may be reasonably request to provide in
connection with the offering or other distribution of Registrable Securities by such Holder or Holders; and 
 (d)    on
receipt of written notice from the Company of the happening of any of the events specified in Section 3.1(m) or Section 3.1(n), or that requires the suspension by such Holder or Holders and their
respective Affiliates of the distribution of any of the Registrable Securities owned by such Holder or Holders, then such Holders shall, and they shall cause their respective Affiliates to, cease offering or distributing the Registrable Securities
owned by such Holder or Holders until the offering and distribution of the Registrable Securities owned by such Holder or Holders may recommence in accordance with the terms hereof and applicable law. 

Section 3.5 Rule 144 Reporting. With a view to making available the benefits of Rule 144 to the Holders, the Company agrees that,
for so long as a Holder owns Registrable Securities or Series B Eligible Stock, the Company will use reasonable best efforts to: 

(a)    make and keep public information available, as those terms are understood and defined in Rule 144; 

(b)    file with the Commission in a timely manner all reports and other documents required of the Company under the
Exchange Act; and 
 (c)    so long as a Holder owns any Restricted Securities or Series B Eligible Stock, furnish to
the Holder forthwith upon written request a written statement by the Company as to its compliance with the reporting requirements of the Exchange Act. 

Section 3.6 “Market Stand-Off” Agreement. The Holders shall
not sell, transfer, make any short sale of, grant any option for the purchase of, or enter into any hedging or similar transaction with the same economic effect as a sale with respect to, any Common Stock (or other securities of the Company) held by
the Holders (other than those included in the registration) for a period specified by the representatives of the managing underwriter or underwriters of Common Stock (or other securities of the Company convertible into Common Stock) not to exceed
five (5) days prior and ninety (90) days following any registered public sale of securities by the Company in which the Company gave the Holders an opportunity to participate in accordance with Article II. Each of the Holders also
shall execute and deliver any “lock-up” agreement reasonably requested by the representatives of any underwriters of the Company. 

  
 7 

 Section 3.7 Insider Trading Policy. So long as any designee or nominee of the
Holders or their Affiliates sits on the Board of Directors of the Company, the Holders shall, and shall cause their Affiliates, to comply with the Company’s insider trading policy. 

ARTICLE IV 

INDEMNIFICATION 

Section 4.1 Indemnification by Company. To the extent permitted by applicable law, the Company will, with respect to any
Registrable Securities as to which registration or qualification or compliance under applicable “blue sky” laws has been effected pursuant to this Agreement, indemnify each Holder, each Holder’s current and former officers, directors,
partners and members, and each Person controlling such Holder within the meaning of Section 15 of the Securities Act, and each underwriter thereof, if any, and each Person who controls any such underwriter within the meaning of Section 15
of the Securities Act (collectively, the “Company Indemnified Parties”), against all expenses, claims, losses, damages and liabilities, joint or several, (or actions in respect thereof) arising out of or based on any untrue
statement (or alleged untrue statement) of a material fact contained in any registration statement, prospectus, preliminary prospectus, offering circular or other document, or any amendment or supplement thereto incident to any such registration,
qualification or compliance or based on any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they were made, not
misleading, or any violation by the Company of any rule or regulation promulgated under the Securities Act, Exchange Act or state securities laws applicable to the Company in connection with any such registration, and the Company will reimburse each
of the Company Indemnified Parties for any reasonable legal and any other expenses reasonably incurred in connection with investigating, preparing or defending any such claim, loss, damage, liability or action, as such expenses are incurred. The
indemnity agreement contained in this Section 4.1 shall not apply to amounts paid in settlement of any loss, claim, damage, liability or action if such settlement is effected without the prior written consent of the Company
(which consent shall not be unreasonably withheld or delayed), nor shall the Company be liable to a Holder in any such case for any such loss, claim, damage, liability or action to the extent that it arises out of or is based upon a violation or
alleged violation of any state or federal law (including any claim arising out of or based on any untrue statement or alleged untrue statement or omission or alleged omission in the registration statement or prospectus) which occurs in reliance upon
or in conformity with written information furnished expressly for use in connection with such registration by or on behalf of any Holder. 

Section 4.2 Indemnification by Holders. To the extent permitted by applicable law, each Holder will, if Registrable Securities
held by such Holder are included in the securities as to which such registration or qualification or compliance under applicable “blue sky” laws is being effected, indemnify, severally and not jointly, the Company, each of its directors,
officers, partners and members, each underwriter, if any, of the Company’s securities covered by such a registration, each Person who controls the Company or such underwriter within the meaning of Section 15 of the Securities Act, and each
other Holder and each of such Holder’s officers, directors, partners and members and each Person controlling such Holder within the meaning of Section 15 of the Securities Act (collectively, the “Holder Indemnified
Parties”), against all expenses, claims, losses, damages and liabilities (or actions in respect thereof) arising out of or based on any untrue statement (or alleged untrue statement) of a material fact contained in any registration
statement, prospectus, preliminary prospectus, offering circular or other document, or any amendment or supplement thereto incident to any such registration, qualification or compliance or based on any omission (or alleged omission) to state therein
a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading, or any violation by such Holder of any rule or regulation promulgated under the
Securities Act, Exchange Act or state securities law applicable to such Holder, and will reimburse each of the Holder Indemnified Parties for any reasonable legal or any other expenses reasonably incurred in connection with investigating, preparing
or defending 

  
 8 

 
any such claim, loss, damage, liability or action, as such expenses are incurred, in each case to the extent, but only to the extent, that such untrue statement (or alleged untrue statement) or
omission (or alleged omission) is made in such registration statement, prospectus, offering circular or other document in reliance upon or in conformity with written information furnished to the Company by such Holder and stated to be specifically
for use therein, provided, however, that in no event shall any indemnity under this Section 4.2 payable by a Holder exceed the amount by which the net proceeds actually received by such Holder from the
sale of Registrable Securities included in such registration exceeds the amount of any other losses, expenses, settlements, damages, claims and liabilities that such Holder has been required to pay by reason of such untrue or alleged untrue
statement or omission or alleged omission or violation. The indemnity agreement contained in this Section 4.2 shall not apply to amounts paid in settlement of any loss, claim, damage, liability or action if such settlement
is effected without the prior written consent of the applicable Holder (which consent shall not be unreasonably withheld or delayed). 

Section 4.3 Notification. Each party entitled to indemnification under this Article IV (the “Indemnified
Party”) shall give notice to the party required to provide indemnification (the “Indemnifying Party”) promptly after such Indemnified Party has actual knowledge of any claim as to which indemnity may be sought, and shall
permit the Indemnifying Party to assume the defense of any such claim or any litigation resulting therefrom, provided, however, that counsel for the Indemnifying Party, who shall conduct the defense of such claim or litigation, shall
be approved by the Indemnified Party (whose approval shall not unreasonably be withheld or delayed), and the Indemnified Party may participate in such defense at such party’s expense; provided, further, however, that an
Indemnified Party (together with all other Indemnified Parties) shall have the right to retain one (1) separate counsel, with the reasonable fees and expenses to be paid by the Indemnifying Party, if representation of such Indemnified Party by
the counsel retained by the Indemnifying Party would be inappropriate due to conflicting interests between such Indemnified Party and any other party represented by such counsel in such proceeding. The failure of any Indemnified Party to give notice
as provided herein shall relieve the Indemnifying Party of its obligations under this Article IV, only to the extent that, the failure to give such notice is materially prejudicial or harmful to an Indemnifying Party’s ability to defend
such action. No Indemnifying Party, in the defense of any such claim or litigation, shall, except with the prior written consent of each Indemnified Party (which consent shall not be unreasonably withheld or delayed), consent to entry of any
judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release from all liability in respect to such claim or litigation. The indemnity
agreements contained in this Article IV shall not apply to amounts paid in settlement of any loss, claim, damage, liability or action if such settlement is effected without the prior written consent of the Indemnifying Party, which consent
shall not be unreasonably withheld or delayed. The indemnification set forth in this Article IV shall be in addition to any other indemnification rights or agreements that an Indemnified Party may have. 

Section 4.4 Contribution. If the indemnification provided for in this Article IV is held by a court of competent
jurisdiction to be unavailable to an Indemnified Party, other than pursuant to its terms, with respect to any claim, loss, damage, liability or action referred to therein, then, subject to the limitations contained in Article IV, the
Indemnifying Party, in lieu of indemnifying such Indemnified Party hereunder, shall contribute to the amount paid or payable by such Indemnified Party as a result of such claim, loss, damage, liability or action in such proportion as is appropriate
to reflect the relative fault of the Indemnifying Party on the one hand and the Indemnified Party on the other in connection with the actions that resulted in such claims, loss, damage, liability or action, as well as any other relevant equitable
considerations. The relative fault of the Indemnifying Party and of the Indemnified Party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material
fact related to information supplied by the Indemnifying Party or by the Indemnified Party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the
Holders agree that it would not be just 

  
 9 

 
and equitable if contribution pursuant to this Section 4.4 were based solely upon the number of entities from whom contribution was requested or by any other method of
allocation which does not take account of the equitable considerations referred to above in this Section 4.4. In no event shall any Holder’s contribution obligation under this Section 4.4
exceed the amount by which the net proceeds actually received by such Holder from the sale of Registrable Securities included in such registration exceeds the amount of any other losses, expenses, settlements, damages, claims and liabilities that
such Holder has been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission or violation. No Person guilty of fraudulent misrepresentation (within the meaning of the Securities Act) shall be entitled to
contribution from any Person who was not guilty of such fraudulent misrepresentation. 
 ARTICLE V 

TRANSFER AND TERMINATION OF REGISTRATION RIGHTS 

Section 5.1 Transfer of Registration Rights. The rights to cause the Company to register securities granted to a Holder under this
Agreement may be assigned to a Permitted Transferee in connection with any transfer or assignment of Registrable Securities to such Permitted Transferee in accordance with the Subscription Agreement; provided, however, that
(a) such transfer is otherwise effected in accordance with applicable securities laws, (b) prior written notice of such assignment is given to the Company, and (c) such Permitted Transferee agrees in writing to be bound by, and
subject to, this Agreement as a “Holder” pursuant to a written instrument in form and substance reasonably acceptable to the Company. 

Section 5.2 Termination of Registration Rights. The rights of any particular Holder to cause the Company to register securities
under Articles I and II shall terminate with respect to such Holder upon the date upon which such Holder no longer holds any Registrable Securities. 

ARTICLE VI 

MISCELLANEOUS. 

Section 6.1 Counterparts. This Agreement may be executed in one or more counterparts, all of which shall be considered one and the
same agreement, and will become effective when one or more counterparts have been signed by a party and delivered to the other parties. Copies of executed counterparts transmitted by telecopy, telefax or other electronic transmission service shall
be considered original executed counterparts for purposes of this Section 6.1, provided that receipt of copies of such counterparts is confirmed. 

Section 6.2 Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the state of New
York, without giving effect to any choice of law or conflict of law rules or provisions (whether of the state of New York or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the state of New York.

 Section 6.3 Binding Arbitration. 

(a)    The parties hereto desire and agree that any arbitration proceedings shall be conducted before one arbitrator to be
selected pursuant to the Comprehensive Arbitration Rules (the “Arbitrator”) as expeditiously as possible and acknowledge that expeditious arbitration is in the interest of the parties hereto. The parties hereto agree that the
arbitration must be concluded, including the rendering of any award by the Arbitrator (the “Award”), not more than ninety (90) days following selection of the Arbitrator. The parties hereto further agree that the Arbitrator
shall have the authority to impose any interim deadlines, including shortening any deadlines provided in the Comprehensive Arbitration Rules, to ensure that this ninety (90)-day deadline is met. The Arbitrator
must agree to the foregoing ninety (90) day deadline before accepting appointment. Failure to meet the ninety (90) day deadline, however, will not render the Award invalid, unenforceable or subject to being vacated. However, the parties
hereto may 

  
 10 

 
mutually agree to modify the ninety (90)-day deadline and, if they do so, the Arbitrator shall accommodate such parties’ mutual agreement. The
Arbitrator shall have no power to alter or disregard any express language in this Agreement and may not reform this Agreement under equitable or other principles. 

(b)    The parties hereto shall maintain the confidential nature of the arbitration proceeding, except as may be necessary
in connection with a court application for a provisional or preliminary remedy, a court action to challenge or enforce the Award, or as otherwise required by law or judicial decision. The parties hereto further agree that the Arbitrator shall render
the Award in writing and explain the decision which, to the extent possible, shall not include confidential information. 

(c)    The parties hereto waive to the fullest extent permitted by law any rights to appeal or to review of the Award by
any court or tribunal. 
 (d)    For the avoidance of doubt, in the event of a conflict between this
Section 6.3 and the Comprehensive Arbitration Rules, this Section 6.3 controls. 

Section 6.4 Entire Agreement; No Third Party Beneficiary. This Agreement and the Subscription Agreement contain the entire
agreement by and among the parties with respect to the subject matter hereof and all prior negotiations, writings and understandings relating to the subject matter of this Agreement. Except as provided in Article IV, this Agreement is not
intended to confer upon any Person not a party hereto (or their successors and permitted assigns) any rights or remedies hereunder. 

Section 6.5 Expenses. Except as provided in Section 3.3, all fees, costs and expenses incurred in
connection with this Agreement and the transactions contemplated hereby, including accounting and legal fees shall be paid by the party incurring such expenses. 

Section 6.6 Notices. All notices, requests, demands and other communications under this Agreement shall be in writing and shall be
deemed to have been duly given or made as follows: (a) if sent by registered or certified mail in the United States return receipt requested, upon receipt; (b) if sent by nationally recognized overnight air courier, one (1) business
day after mailing; (c) if sent by e-mail transmission, upon receipt; and (d) if otherwise actually personally delivered, when delivered, provided, that such notices, requests, demands and
other communications are delivered to the address set forth below, or to such other address as any party shall provide by like notice to the other Parties to this Agreement: 

If to the Company, to: 
 Digimarc
Corporation 
 9405 SW Gemini Drive 

Beaverton, OR 97008 
 Attention:
Robert Chamness 
 Email: rchamness@digimarc.com 

with a copy (which shall not constitute notice) to: 

Perkins Coie LLP 
 1120 NW Couch
Street, 10th Floor 
 Portland, OR 97209-4128 

Attention: Roy W. Tucker; Gina Eiben 

Facsimile: (503) 727-2222 

Email: rtucker@perkinscoie.com; geiben@perkinscoie.com 

If to the Investor, to: 

  
 11 

 TCM Strategic Partners L.P. 

26 Tahiti Beach Island Road 

Coral Gables, FL 33143 

Attention: Riley McCormack 
 E-mail: rm@tracercap.com 
 with a copy (which shall not constitute notice) to: 

Sidley Austin LLP 
 555
California Street, Suite 2000 
 San Francisco, California 94104 

Attention: Vijay S. Sekhon and Benson Cohen 

E-mail: vsekhon@sidley.com and brcohen@sidley.com 

Section 6.7 Successors and Assigns. This Agreement will be binding upon and inure to the benefit of the parties hereto and their
respective successors and permitted assigns. Except as provided in Section 5.1, no assignment of this Agreement or of any rights or obligations hereunder may be made by any party hereto without the prior written consent of
the other parties hereto. Any purported assignment or delegation in violation of this Agreement shall be null and void ab initio. 

Section 6.8 Headings. The Section, Article and other headings contained in this Agreement are inserted for convenience of
reference only and will not affect the meaning or interpretation of this Agreement. 
 Section 6.9 Amendments and Waivers. This
Agreement may not be modified or amended except by an instrument or instruments in writing signed by the Company and the Holders of a majority of the Registrable Securities outstanding at the time of such amendment. Any party hereto may, only by an
instrument in writing, waive compliance by any other party or parties hereto with any term or provision hereof on the part of such other party or parties hereto to be performed or complied with. No failure or delay of any party in exercising any
right or remedy hereunder shall operate as a waiver thereof, nor will any single or partial exercise of any right or power, or any abandonment or discontinuance of steps to enforce such right or power, preclude any other or further exercise thereof
or the exercise of any other right or power. The waiver by any party hereto of a breach of any term or provision hereof shall not be construed as a waiver of any subsequent breach. The rights and remedies of the parties hereunder are cumulative and
are not exclusive of any rights or remedies that they would otherwise have hereunder. 
 Section 6.10 Interpretation; Absence of
Presumption. 
 (a)    For the purposes hereof: (i) words in the singular shall be held to include the plural
and vice versa and words of one gender shall be held to include the other gender as the context requires; (ii) the terms “hereof,” “herein,” and “herewith” and words of similar import shall, unless otherwise
stated, be construed to refer to this Agreement as a whole and not to any particular provision of this Agreement, and Section and paragraph references are to the Sections and paragraphs in this Agreement unless otherwise specified; (iii) the
word “including” and words of similar import when used in this Agreement shall mean “including, without limitation,” unless the context otherwise requires or unless otherwise specified; and (iv) the word “or” shall
not be exclusive. 
 (b)    With regard to each and every term and condition of this Agreement, the parties hereto
understand and agree that the same have or has been mutually negotiated, prepared and drafted, and if at any time the parties hereto desire or are required to interpret or construe any such term or condition, no consideration will be given to the
issue of which party hereto actually prepared, drafted or requested any term or condition of this Agreement. 

  
 12 

 Section 6.11 Severability. Any provision hereof that is held to be invalid,
illegal or unenforceable in any respect by a court of competent jurisdiction, shall be ineffective only to the extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining provisions hereof, provided,
however, that the parties will attempt in good faith to reform this Agreement in a manner consistent with the intent of any such ineffective provision for the purpose of carrying out such intent. 

(The next page is the signature page) 

  
 13 

 IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written. 
  

			
	DIGIMARC CORPORATION
		
	By:	 	 /s/ Robert P. Chamness

		 	Name: Robert P. Chamness
		 	 Title: Executive Vice President, Chief Legal

          Officer and Secretary

	
	 TCM STRATEGIC PARTNERS L.P.
  

By: TCM Strategic GP LLC, its general partner

		
	By:	 	 /s/ Riley McCormack

		 	Name: Riley McCormack
		 	Title: Manager

 [Signature Page to Registration Rights Agreement] 

  
 S-1 

 EXHIBIT A 

DEFINED TERMS 
 1.
The following capitalized terms have the meanings indicated: 
 “Affiliate” of any Person means any Person, directly or
indirectly, controlling, controlled by or under common control with such Person. 
 “Automatic Shelf Registration
Statement” means an “automatic shelf registration statement” as defined under Rule 405. 
 “Commission”
means the Securities and Exchange Commission. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended, or
any similar successor federal statute, and the rules and regulations of the Commission thereunder, all as the same shall be in effect from time to time. 

“Excluded Registration” means (i) a registration relating to the sale or grant of securities to employees of the Company
or a subsidiary pursuant to a stock option, stock purchase, equity incentive or similar plan; (ii) a registration relating to an SEC Rule 145 transaction; or (iii) a registration in which the only Common Stock being registered is Common
Stock issuable upon conversion of debt securities that are also being registered. 
 “Holder” means (a) the Investor
and (b) any Permitted Transferee to which the rights under this Agreement have been transferred in accordance with Section 5.1. 

“Permitted Transferee” has the meaning given to such term in the Subscription Agreement. 

“Person” means an individual, corporation, partnership, limited liability company, joint venture, association, trust,
unincorporated organization, other legal entity, or any government or governmental agency or authority. 
 “register”,
“registered” and “registration” refer to a registration effected by preparing and filing a registration statement in compliance with the Securities Act, and the declaration or ordering of the effectiveness of such
registration statement. 
 “Registration Expenses” means (a) all expenses incurred by the Company in complying with
Articles I and II, including, without limitation, all registration, qualification, listing and filing fees, printing expenses, escrow fees, fees and disbursements of counsel for the Company, blue sky fees and expenses, and the expense
of any special audits incident to or required by any such registration; and (b) the fees and expenses of any counsel to the Holders; provided, however, that, in the case of this clause (b), such fees and expenses shall not exceed
$25,000 with respect to any particular registration pursuant to Article I or II. 
 “Registrable Securities”
means (a) the Closing Shares (as defined in the Subscription Agreement), (b) any shares of Common Stock actually issued upon conversion of the Series B Convertible Preferred Stock, and (c) any other shares of Common Stock issued in respect
of the securities described in clauses (a) or (b) above upon any stock split, stock dividend, recapitalization, reclassification, merger, consolidation or similar event; provided, however, that the securities described in clauses
(a), (b) and (c) above shall only be treated as Registrable Securities until the earliest of: (i) the date on which such security has been registered under the Securities Act and disposed of in accordance with an effective registration
statement relating thereto; (ii) the date on which such security may be transferred or sold without restriction (including with respect to time, volume and manner of sale) under Rule 144; or (iii) the date on which such security is
transferred in a transaction pursuant to which the registration rights are not also assigned in accordance with Section 5.1. 

  
 A-1 

 “Restricted Securities” means any Common Stock required to bear the legend
set forth in Section 4.3(a) of the Subscription Agreement. 
 “Rule 144” means Rule 144 promulgated under the
Securities Act and any successor provision. 
 “Rule 405” means Rule 405 promulgated under the Securities Act and any
successor provision. 
 “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations
promulgated thereunder or any similar federal statute and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time. 

“Selling Expenses” means all underwriting discounts, selling commissions and stock transfer taxes applicable to the
securities registered by the Holders. 
 “Series B Eligible Stock” means Series B Convertible Preferred Stock until the
earlier of: (i) the date on which such security may be transferred or sold without restriction (including with respect to time, volume and manner of sale) under Rule 144; or (ii) the date on which such security is transferred in a
transaction pursuant to which the rights under this Agreement are not also assigned in accordance with Section 5.1. 

“Shelf Registration” means the Resale Shelf Registration or a Subsequent Shelf Registration, as applicable. 

“WKSI” means a “well-known seasoned issuer” as defined under Rule 405. 

2. The following terms are defined in the Sections of the Agreement indicated: 

INDEX OF TERMS 
  

			
	 Term
	  	 Section

	Agreement	  	Preamble
	Arbitrator	  	Section 6.2(a)
	Award	  	Section 6.2(a)
	Company	  	Preamble
	Company Indemnified Parties	  	Section 4.1
	Effectiveness Period	  	Section 1.2
	Holder	  	Section 5.1
	Holder Indemnified Parties	  	Section 4.2
	Indemnified Party	  	Section 4.3
	Indemnifying Party	  	Section 4.3
	Investor	  	Preamble
	Market Stand-Off	  	Section 3.6
	Resale Shelf Registration	  	Section 1.1
	Resale Shelf Registration Statement	  	Section 1.1
	Subscription Agreement	  	Preamble
	Subsequent Holder Notice	  	Section 1.5
	Subsequent Shelf Registration	  	Section 1.3
	Underwritten Offering	  	Section 1.6(b)

  
 A-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}]]